Sources, in context.
Research supports the answers. Community discussions explain why the questions were selected.
References
46 sources
Selected primary studies and official regulatory documents, checked 3–4 October 2026.
- Primary research · Human study · 2021Intra-Articular Injection of BPC 157 for Multiple Types of Knee PainRead review · DraftSave study
- Primary research · Preclinical · 2026Effects of BPC-157 and TB-500 on Achilles tendon healing in rats: A histopathological and biomechanical studyRead review · DraftSave study
- Regulatory guidance · Accessed 2026-10-03Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety RisksSave study
- Primary research · 2006Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adultsReview status · PendingSave studyUsed in CJC-1295CJC-1295 + ipamorelin
- Human pharmacology study · 1999Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteersReview status · PendingSave study
- Primary research · 2006Effects of topical copper tripeptide complex on CO2 laser-resurfaced skinReview status · PendingSave studyUsed in GHK-CuGLOW stack
- Primary research · Cells and mice · 2008PepT1-mediated tripeptide KPV uptake reduces intestinal inflammationReview status · PendingSave studyUsed in KLOW stack
- Primary research · Preclinical · 2025Stable Gastric Pentadecapeptide BPC 157 as Therapy After Surgical Detachment of the Quadriceps Muscle from Its Attachments for Muscle-to-Bone Reattachment in RatsReview status · PendingSave studyUsed in BPC-157
- Primary research · Preclinical · 2021Stable Gastric Pentadecapeptide BPC 157 as a Therapy for the Disable Myotendinous Junctions in RatsReview status · PendingSave studyUsed in BPC-157
- Primary research · Preclinical · 2010Impact of pentadecapeptide BPC 157 on muscle healing impaired by systemic corticosteroid applicationReview status · PendingSave studyUsed in BPC-157
- Primary research · Preclinical · 2004Protective effects of pentadecapeptide BPC 157 on gastric ulcer in ratsReview status · PendingSave studyUsed in BPC-157
- Primary research · Preclinical · 2021Robert’s Intragastric Alcohol-Induced Gastric Lesion Model as an Escalated General Peripheral and Central Syndrome, Counteracted by the Stable Gastric Pentadecapeptide BPC 157Review status · PendingSave studyUsed in BPC-157
- Regulatory assessment · 2026FDA Briefing Document: BPC-157-related bulk drug substances, July 2026 Pharmacy Compounding Advisory CommitteeSave studyUsed in BPC-157
- Primary research · Human study · 2024Effect of BPC-157 on Symptoms in Patients with Interstitial Cystitis: A Pilot StudyRead review · DraftSave studyUsed in BPC-157
- Primary research · Preprint, not peer reviewed · 2026Rising Use of Unapproved BPC-157 (“Wolverine Peptide”) and Associated Patient-Reported Outcomes Curated from Clinical NotesReview status · PendingSave studyUsed in BPC-157
- Primary research · Human study · 2025Safety of Intravenous Infusion of BPC157 in Humans: A Pilot StudyRead review · DraftSave studyUsed in BPC-157
- Primary research · Preclinical · 2014Pentadecapeptide BPC 157 Enhances the Growth Hormone Receptor Expression in Tendon FibroblastsRead review · DraftSave studyUsed in BPC-157
- Primary research · Preclinical · 2022Pharmacokinetics, distribution, metabolism, and excretion of body-protective compound 157, a potential drug for treating various wounds, in rats and dogsReview status · PendingSave studyUsed in BPC-157
- Primary research · 20230.1% RGN-259 (Thymosin ß4) Ophthalmic Solution Promotes Healing and Improves Comfort in Neurotrophic Keratopathy Patients in a Randomized, Placebo-Controlled, Double-Masked Phase III Clinical TrialReview status · PendingSave studyUsed in TB-500
- Primary research · 2014Prospective, randomized, controlled, proof-of-concept study of the Ghrelin mimetic ipamorelin for the management of postoperative ileus in bowel resection patientsReview status · PendingSave studyUsed in Ipamorelin
- Primary research · 2021Once-Weekly Semaglutide in Adults with Overweight or ObesityReview status · PendingSave studyUsed in Semaglutide
- Primary research · 2022Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extensionReview status · PendingSave studyUsed in Semaglutide
- Primary research · 2022Tirzepatide Once Weekly for the Treatment of ObesityReview status · PendingSave studyUsed in Tirzepatide
- Primary research · 2025Tirzepatide as Compared with Semaglutide for the Treatment of ObesityReview status · PendingSave studyUsed in Tirzepatide
- Primary research · 2024Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical TrialReview status · PendingSave studyUsed in Tirzepatide
- Primary research · 200824-Week study on the use of collagen hydrolysate as a dietary supplement in athletes with activity-related joint painReview status · PendingSave studyUsed in Collagen peptides
- Primary research · 2014Oral supplementation of specific collagen peptides has beneficial effects on human skin physiology: a double-blind, placebo-controlled studyReview status · PendingSave studyUsed in Collagen peptides
- Primary research · 2024Safety and Risk Assessment of No-Prescription Online Semaglutide PurchasesReview status · PendingSave studyUsed in Semaglutide
- Regulatory labeling · 2026WEGOVY U.S. Prescribing Information, revised June 2026Save studyUsed in Semaglutide
- Regulatory assessment · Accessed 2026-10-03FDA: Concerns with Unapproved GLP-1 Drugs Used for Weight LossSave studyUsed in SemaglutideTirzepatide
- Regulatory guidance · Accessed 2026-10-03Understanding the Risks of Compounded DrugsSave study
- Regulatory labeling · 2026ZEPBOUND U.S. Prescribing Information, revised August 2026Save studyUsed in Tirzepatide
- Primary research · 20230.1% RGN-259 (Thymosin ß4) Ophthalmic Solution Promotes Healing and Improves Comfort in Neurotrophic Keratopathy Patients in a Randomized, Placebo-Controlled, Double-Masked Phase III Clinical TrialReview status · PendingSave studyUsed in TB-500
- Regulatory guidance · Accessed 2026-10-03Cosmetics & U.S. LawSave studyUsed in GHK-Cu
- Regulatory assessment · 2024December 4, 2024 Pharmacy Compounding Advisory Committee Meeting: FDA presentation on CJC-1295Save studyUsed in CJC-1295
- Case report · 2020A case of pediatric anaphylaxis caused by gummy tablets containing fish collagenReview status · PendingSave studyUsed in Collagen peptides
- Regulatory guidance · Accessed 2026-10-03Mixing Medications and Dietary Supplements Can Endanger Your HealthSave studyUsed in Collagen peptides
- Regulatory guidance · Accessed 2026-10-03Questions and Answers on Dietary SupplementsSave studyUsed in Collagen peptides
- Primary research · Preclinical · 2009Modulatory effect of gastric pentadecapeptide BPC 157 on angiogenesis in muscle and tendon healingReview status · PendingSave studyUsed in
- Primary research · Preclinical · 2026BPC157 drives angiogenesis through FBXO22-dependent stabilization of BACH1Review status · PendingSave studyUsed in
- Primary research · Preclinical · 2021BPC 157 as a Therapy for Retinal Ischemia Induced by Retrobulbar Application of L-NAME in RatsReview status · PendingSave studyUsed in
- Primary research · Preclinical · 2021Stable Gastric Pentadecapeptide BPC 157 Therapy for Monocrotaline-Induced Pulmonary Hypertension in Rats Leads to Prevention and ReversalReview status · PendingSave studyUsed in
- Primary research · Preclinical · 2021Occluded Superior Mesenteric Artery and Vein. Therapy with the Stable Gastric Pentadecapeptide BPC 157Review status · PendingSave studyUsed in
- Primary research · Preclinical · 2020Pentadecapeptide BPC 157 resolves suprahepatic occlusion of the inferior caval vein, Budd-Chiari syndrome model in ratsReview status · PendingSave studyUsed in
- Primary research · Preclinical · 2021Stable Gastric Pentadecapeptide BPC 157 Therapy for Primary Abdominal Compartment Syndrome in RatsReview status · PendingSave studyUsed in
- Primary research · Preclinical · 2022Fourier Transform Infrared Spectroscopy Reveals Molecular Changes in Blood Vessels of Rats Treated with Pentadecapeptide BPC 157Review status · PendingSave studyUsed in
Studies
Each paper appears once, with its findings and available PDF records inside each expandable study. References above identify sources cited by the guides; community discussions below explain how questions were selected and are not clinical evidence.
0.1% RGN-259 (Thymosin ß4) Ophthalmic Solution Promotes Healing and Improves Comfort in Neurotrophic Keratopathy Patients in a Randomized, Placebo-Controlled, Double-Masked Phase III Clinical Trial
A Pharmacometric Method for Quantitative Determination of Improvement in Body Composition and Characterization of the Exposure–Response Relationship during Treatment of Obesity with Tirzepatide
A Phase 1 Multiple Dose Study of Tirzepatide in Chinese Patients with Type 2 Diabetes
A Torilis japonica Extract–GHK-Cu Complex Attenuates Th2 Cytokines and Promotes Keratinocyte Recovery: A Potential Antioxidant Strategy for Atopic Dermatitis
A feasibility and safety study of afamelanotide in acute stroke patients – an open label, proof of concept, phase iia clinical trial
A first-in-human, randomized, double-blind, single- and multiple-dose, phase I study of recombinant human thymosin β4 in healthy Chinese volunteers
A gene expression signature of emphysemarelated lung destruction and its reversal by the tripeptide GHK
A phase 1 evaluation of inhaled oxytocin: Physiologicallybased pharmacokinetic model informed dosing of a novel heat-stable oxytocin delivery system
A phase 1 multiple-ascending dose study of tirzepatide in Japanese participants with type 2 diabetes
A randomized, double-blind, prospective, placebo-controlled study of the efficacy of a diet supplemented with curcuminoids extract, hydrolyzed collagen and green tea extract in owner’s dogs with osteoarthritis
Absorption of bioactive peptides following collagen hydrolysate intake: a randomized, double-blind crossover study in healthy individuals
Antiarrhythmic Sotalol, Occlusion/Occlusion-like Syndrome in Rats, and Stable Gastric Pentadecapeptide BPC 157 Therapy
Apitegromab for lean mass preservation during tirzepatide-induced weight loss: a randomized, double-blind, placebo-controlled phase 2 trial
Artificial intelligence scoring of liver biopsies in a phase II trial of semaglutide in nonalcoholic steatohepatitis
Association between weight reduction achieved with tirzepatide and quality of life in adults with obesity: Results from the SURMOUNT-1 study
Association of baseline characteristics with clinical outcomes of tirzepatide treatment in Japanese patients with obesity disease: A subgroup analysis of the SURMOUNT-J trial
Association of serum thymosin β4 with malnutrition-inflammation-atherosclerosis syndrome in peritoneal dialysis patients: a cross-sectional study
Association of tirzepatide with changes in OSA‑related measures based on baseline characteristics – post hoc analyses of SURMOUNT‑OSA
Attenuation of Visceral and Somatic Nociception by Ghrelin Mimetics
Augmented Skin Beneficial Effects of Thermus Thermophilus and Bacillus Subtilis Mixed-Culture Ferment Extract by Tripeptide GHK-Cu
BPC 157 Therapy and the Permanent Occlusion of the Superior Sagittal Sinus in Rat: Vascular Recruitment
BPC 157 as a Therapy for Retinal Ischemia Induced by Retrobulbar Application of L-NAME in Rats
- Population
- Rat
- Finding and limits
- The investigators reported preservation of retinal layers after L-NAME-induced injury in rats. This experimental eye-injection model does not establish human visual or neurological benefit.
Relevant PDF pages: 6, 4.
Bimagrumab plus semaglutide alone or in combination for the treatment of obesity: a randomized phase 2 trial
Body composition changes during weight reduction with tirzepatide in the SURMOUNT-1 study of adults with obesity or overweight
Bypassing major venous occlusion and duodenal lesions in rats, and therapy with the stable gastric pentadecapeptide BPC 157, L-NAME and L-arginine
Celecoxib-induced gastrointestinal, liver and brain lesions in rats, counteraction by BPC 157 or L-arginine, aggravation by L-NAME
Change in pharmacodynamic variables following once-weekly tirzepatide treatment versus dulaglutide in Japanese patients with type 2 diabetes (SURPASS J-mono substudy
Clopidogrel-Induced Gastric Injury in Rats is Attenuated by Stable Gastric Pentadecapeptide BPC 157
Collagen Peptides from Swim Bladders of Giant Croaker (Nibea japonica) and Their Protective Effects against H2O2-Induced Oxidative Damage toward Human Umbilical Vein Endothelial Cells
COLLAGEN- AND COLLAGEN PEPTIDE-INDUCED CHEMOTAXIS OF HUMAN BLOOD MONOCYTES
Collagen peptide supplementation in combination with resistance training improves body composition and increases muscle strength in elderly sarcopenic men: a randomised controlled trial
Combined Phase 1/2a Initial Clinical Safety Trials and Proof‐of‐Concept Assessment of a Novel Antimicrobial Peptide KSL‐W Anti‐Plaque Chewing Gum
Comparative Efficacy and Safety of Once-Weekly Semaglutide Formulations in Indian Adults With Obesity: A Phase III, Randomized Non-inferiority Active-Controlled Study (Size Plus Study
Comparative effectiveness of sleeve gastrectomy and semaglutide for weight loss and metabolic outcomes: a prospective non‑randomized study
Comparative effects of MKARE® eggshell membrane and hydrolyzed collagen as nutricosmetics on skin biophysical properties: a randomized clinical trial
Complex Syndrome of the Complete Occlusion of the End of the Superior Mesenteric Vein, Opposed with the Stable Gastric Pentadecapeptide BPC 157 in Rats
Counteraction of perforated cecum lesions in rats: Effects of pentadecapeptide BPC 157, L-NAME and L-arginine
Counterregulatory response to hypoglycemia during a hypoglycemic clamp in people with type 2 diabetes treated with tirzepatide
Development of Functional Soybean-Enriched Cheese: Identification of Novel Angiotensin-Converting Enzyme-Inhibitory and Predicted Dipeptidyl Peptidase IV-Related Peptides
Dietary Supplementation with Specific Collagen Peptides Has a Body Mass Index-Dependent Beneficial Effect on Cellulite Morphology
Dose–response effects on HbA1c and bodyweight reduction of survodutide, a dual glucagon/GLP‑1 receptor agonist, compared with placebo and open‑label semaglutide in people with type 2 diabetes: a randomised clinical trial
Dynamic modulation of LH secretion by continuous kisspeptin infusion in healthy men
Early Fasting Serum Glucose or Weight Reduction With Tirzepatide and Metabolic Outcomes in People With Type 2 Diabetes: A Post Hoc Analysis of the SURPASS Trials
Ectopic Expression of Human Thymosin β4 Confers Resistance to Legionella pneumophila during Pulmonary and Systemic Infection in Mice
Effect of BPC-157 on Symptoms in Patients with Interstitial Cystitis: A Pilot Study
- Population
- Human
- Finding and limits
- Ten of twelve women reported complete symptom resolution after bladder injections, and two reported partial improvement. There was no control group, and questionnaire timing is described inconsistently.
Relevant PDF pages: 3, 2.
Effect of Semaglutide on the Inflammatory Biomarker High-Sensitivity CRP in Patients With Established Cardiovascular Disease and Overweight or Obesity in SELECT: A Prespecified Secondary Analysis
Effect of Tirzepatide on Health-Related Quality of Life in Japanese Patients With Obesity Disease: Patient-Reported Outcomes From the SURMOUNT-J Study
Effect of Topical Application of Antimicrobial Peptide PL-5 (Peceleganan) Spray on Mild to Moderate Infection of Diabetic Foot Ulcers: A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Clinical Trial
Effect of β-Casein Fortification in Milk Protein on Digestion Properties and Release of Bioactive Peptides in a Suckling Rat Pup Model
Effect of once-weekly semaglutide versus thrice-daily insulin aspart, both as add-on to metformin and optimized insulin glargine treatment in participants with type 2 diabetes (SUSTAIN 11): A randomized, open-label, multinational, phase 3b trial
Effect of tesamorelin in people with HIV with and without dorsocervical fat: Post hoc analysis of phase III double-blind placebo-controlled trial
Effect of tirzepatide treatment on patient-reported outcomes among SURMOUNT-OSA participants with obstructive sleep apnea and obesity
Effects of BPC-157 and TB-500 on Achilles tendon healing
- Population
- Male Sprague-Dawley rats
- Finding and limits
- BPC-157 alone did not significantly improve maximum load to failure versus control; the combination showed no additional benefit over monotherapy. Only four tendons per group contributed to each endpoint, so nonsignificance does not prove no effect.
Relevant PDF pages: 5, 14.
Effects of Composite Supplement Containing Collagen Peptide and Ornithine on Skin Conditions and Plasma IGF-1 Levels—A Randomized, Double-Blind, Placebo-Controlled Trial
Effects of Diclofenac, L-NAME, L-Arginine, and Pentadecapeptide BPC 157 on Gastrointestinal, Liver, and Brain Lesions, Failed Anastomosis, and Intestinal Adaptation Deterioration in 24 Hour-Short- Bowel Rats
Effects of Novel Dual GIP and GLP-1 Receptor Agonist Tirzepatide on Biomarkers of Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes
Effects of Tirzepatide on the Clinical Trajectory of Patients With Heart Failure, Preserved Ejection Fraction, and Obesity
Effects of collagen peptide supplementation on bone turnover, cytokine, and inflammatory markers in female distance runners: a randomized pilot study
Effects of exercise and liraglutide on vascular health and inflammation during weight loss maintenance: a prespecified secondary analysis of the S-LiTE trial
Effects of insulin and exenatide therapy on glycemic control and β-cell function in patients newly diagnosed with type 2 diabetes and severe hyperglycemia
Effects of once-weekly semaglutide vs once-daily canagliflozin on body composition in type 2 diabetes: a substudy of the SUSTAIN 8 randomised controlled clinical trial
Effects of Sizes and Conformations of Fish-Scale Collagen Peptides on Facial Skin Qualities and Transdermal Penetration Efficiency
Efficacy, Safety, and Tolerability of Oral Semaglutide Versus Placebo Added to Insulin With or Without Metformin in Patients With Type 2 Diabetes: The PIONEER 8 Trial
Efficacy and Safety of Once-Weekly Semaglutide 2.0 mg as an Add-On to Dose-Reduced Insulin Glargine versus Dose-Titrated Insulin Glargine in People With Type 2 Diabetes and Overweight (SUSTAIN OPTIMIZE
Efficacy and Safety of Tirzepatide in Japanese Participants With Obesity: A Subpopulation Analysis of the SURMOUNT-1 Trial
Efficacy and safety in tirzepatide-treated Korean adults with type 2 diabetes—A post hoc analysis of SURPASS-AP-combo and SURPASS-3
Efficacy and safety of low-molecular-weight collagen peptides in knee osteoarthritis: a randomized, double-blind, placebo-controlled trial
Efficacy and safety of novel formulation of semaglutide injection: A multicentre, randomized, comparative, active controlled, phase 3 study in comparison with reference biologic in Indian patients with type 2 diabetes mellitus
Efficacy and safety of once-weekly semaglutide 2.4 mg for weight management in participants from China: A prespecified analysis of the STEP 7 randomized clinical trial
Efficacy and safety of once-weekly semaglutide versus once-daily sitagliptin as add-on to metformin in patients with type 2 diabetes in SUSTAIN China: A 30-week, double-blind, phase 3a, randomized trial
Efficacy and safety of oral semaglutide by baseline age in Japanese patients with type 2 diabetes: A subgroup analysis of the PIONEER 9 and 10 Japan trials
Efficacy and safety of oral semaglutide in Japanese patients with type 2 diabetes: A subgroup analysis by baseline variables in the PIONEER 9 and PIONEER 10 trials
Efficacy and safety of oral semaglutide monotherapy vs placebo in a predominantly Chinese population with type 2 diabetes (PIONEER 11): a double‑blind, Phase IIIa, randomised trial
Efficacy and safety of oral semaglutide vs sitagliptin in a predominantly Chinese population with type 2 diabetes uncontrolled with metformin: PIONEER 12, a double‑blind, Phase IIIa, randomised trial
Efficacy and tolerability of tirzepatide, a dual glucosedependent insulinotropic peptide and glucagon-like peptide-1 receptor agonist in patients with type 2 diabetes: A 12-week, randomized, double-blind, placebo-controlled study to evaluate different dose-escalation regimens
Efficacy and tolerance of enzymatic hydrolysed collagen (EHC) vs. glucosamine sulphate (GS) in the treatment of knee osteoarthritis (KOA
Efficacy of a Complex of 5-Aminolevulinic Acid and Glycyl-Histidyl-Lysine Peptide on Hair Growth
Efficacy of combined undenatured type II collagen and hydrolysed collagen supplementation in knee osteoarthritis: a randomised controlled trial
Efficacy of ipamorelin, a ghrelin mimetic, on gastric dysmotility in a rodent model of postoperative ileus
Efficacy of the melanocortin analogue Nle4-D-Phe7-α-melanocyte-stimulating hormone in the treatment of patients with Hailey–Hailey disease
Endothelium-Dependent Nitric Oxide-Mediated Vasorelaxant Effects of BPC 157 in Human Internal Mammary Artery
Enhanced biological properties of collagen/chitosan‑coated poly(ε‑caprolactone) scaffold by surface modification with GHK‑Cu peptide and 58S bioglass
Enzymatic Hydrolysis of a Collagen Hydrolysate Enhances Postprandial Absorption Rate—A Randomized Controlled Trial
Esophagogastric anastomosis in rats: Improved healing by BPC 157 and L-arginine, aggravated by L-NAME
Evaluation of the Efficacy and Safety of CollaSel PRO® Type I and Type III Hydrolyzed Collagen Peptides in the Treatment of Osteoarthritis: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial
Exenatide Once Weekly in the Treatment of Patients with Multiple System Atrophy
Exploration of Multiple Non-Invasive Tests for Assessing Response to Treatment in a Semaglutide Phase 2b Trial in Patients with MASH
Exploring the beneficial effects of GHK-Cu on an experimental model of colitis and the underlying mechanisms
Expression and localisation of thymosin beta- 4 in the developing human early fetal heart
Fourier Transform Infrared Spectroscopy Reveals Molecular Changes in Blood Vessels of Rats Treated with Pentadecapeptide BPC 157
- Population
- Rat
- Finding and limits
- Aortic tissue spectra differed between treated and control rats. This exploratory study used five animals per group; multiple tissue sections were technical samples, not additional animals.
Relevant PDF pages: 7.
Gastrointestinal tolerability and weight reduction associated with tirzepatide in adults with obesity or overweight with and without type 2 diabetes in the SURMOUNT-1 to -4 trials
Global Proteomics-based Identification and Validation of Thymosin Beta-4 X-Linked as a Prognostic Marker for Head and Neck Squamous Cell Carcinoma
Glycyl-L-histidyl-L-lysine-Cu2+ attenuates cigarette smoke-induced pulmonary emphysema and inflammation by reducing oxidative stress pathway
Glycyl-L-histidyl-L-lysine-Cu2+ rescues cigarette smoking-induced skeletal muscle dysfunction via a sirtuin 1-dependent pathway
Glycyl- l -histidyl- l -lysine prevents copper- and zinc-induced protein aggregation and central nervous system cell death in vitro
Growth Hormone (GH) Hypersecretion and GH Receptor Resistance in Streptozotocin Diabetic Mice in Response to a GH Secretagogue
Hair-Growth-Promoting Effects of the Fish Collagen Peptide in Human Dermal Papilla Cells and C57BL/6 Mice Modulating Wnt/β-Catenin and BMP Signaling Pathways
High-Dose Semaglutide (Up to 16 mg) in People With Type 2 Diabetes and Overweight or Obesity: A Randomized, Placebo-Controlled, Phase 2 Trial
Human Enriched Serum Following Hydrolysed Collagen Absorption Modulates Bone Cell Activity: from Bedside to Bench and Vice Versa
Human skin penetration of a copper tripeptide in vitro as a function of skin layer
Human skin retention and penetration of a copper tripeptide in vitro as function of skin layer towards anti-inflammatory therapy
Hydrolysed Collagen Supplementation Enhances Patellar Tendon Adaptations to 12 Weeks’ Resistance Training in Middle‐Aged Men
Hypomethylation of thymosin β4 promoter is associated with glucocorticoid therapy in patients with acute-on-chronic hepatitis B-induced liver failure
Hypoxia/reoxygenation-experienced cancer cell migration and metastasis are regulated by Rap1- and Rac1-GTPase activation via the expression of thymosin beta-4
Identification of Targets of a New Nutritional Mixture for Osteoarthritis Management Composed by Curcuminoids Extract, Hydrolyzed Collagen and Green Tea Extract
Identifi cation of Thymosin β 4 as an effector of Hand1-mediated vascular development
Impact of a Specific Collagen Peptide Food Supplement on Periodontal Inflammation in Aftercare Patients—A Randomised Controlled Trial
Impact of pentadecapeptide BPC 157 on muscle healing
- Population
- Male Wistar albino rats
- Finding and limits
- BPC-157 improved measured healing after rat muscle crush during methylprednisolone exposure. This experiment cannot establish a safe corticosteroid combination in humans.
Relevant PDF pages: 3, 1.
Impact on HbA1c and body weight of switching from other GLP-1 receptor agonists to semaglutide: A model-based approach
Improved health-related quality of life with tirzepatide versus semaglutide in adults with obesity or overweight from the SURMOUNT-5 trial
Improved laccase production by Trametes versicolor using Copper-Glycyl-L-Histidyl-L-Lysine as a novel and high-efficient inducer
Improvement of Functional Ankle Properties Following Supplementation with Specific Collagen Peptides in Athletes with Chronic Ankle Instability
In Vitro and in Vivo Studies of pH-Sensitive GHK-Cu-Incorporated Polyaspartic and Polyacrylic Acid Superabsorbent Polymer
In relation to NO-System, Stable Pentadecapeptide BPC 157 Counteracts Lidocaine-Induced Adverse Effects in Rats and Depolarisation In Vitro
In Vivo Stimulation of Connective Tissue Accumulation by the Tripeptide-Copper Complex Glycyl-L-histidyl-L-lysine-Cu2+ in Rat Experimental Wounds
Indirect comparative efficacy and safety of tirzepatide 10 and 15 mg versus semaglutide 2.4 mg for the management of obesity and overweight in patients with type 2 diabetes
Ingestion of bioactive collagen hydrolysates enhanced pressure ulcer healing in a randomized double-blind placebo-controlled clinical study
Insulin, Semaglutide and Dapagliflozin in Adults With Type 1 Diabetes: Design and Methods of Triple Therapy for Type 1 Diabetes (TTT1)—An International Phase 3 Clinical Trial
Intra-Articular Injection of BPC 157 for Multiple Types of Knee Pain
- Population
- Human
- Finding and limits
- Sixteen patients were contacted after knee injections; eleven of twelve receiving BPC-157 alone reported improvement. The study had no control group or objective confirmation of tissue repair.
Relevant PDF pages: 3.
Intra-Articular Injection of Hydrolyzed Collagen to Treat Symptoms of Knee Osteoarthritis. A Functional In Vitro Investigation and a Pilot Retrospective Clinical Study
Intragastric Application of Aspirin, Clopidogrel, Cilostazol, and BPC 157 in Rats: Platelet Aggregation and Blood Clot
Intranasal kisspeptin administration rapidly stimulates gonadotropin release in humans
Ixekizumab With Tirzepatide Achieved Greater Disease Control Than Ixekizumab Alone in Adults With Psoriatic Arthritis and Overweight or Obesity: Results From a Randomized Clinical Trial
Liposomes as Carriers of GHK-Cu Tripeptide for Cosmetic Application
Liraglutide in mild to moderate Alzheimer’s disease: a phase 2b clinical trial
Local Photorelease of Caged Thymosin β4 in Locomoting Keratocytes Causes Cell Turning
Long-acting PYY336 analogue with semaglutide for obesity: from preclinical assessment through randomized clinical studies
Long-term comparative effectiveness of once-weekly semaglutide versus alternative treatments in a real-world US adult population with type 2 diabetes: a randomized pragmatic clinical trial
Long-term efficacy and safety of oral semaglutide and the effect of switching from sitagliptin to oral semaglutide in patients with type 2 diabetes: a 52-week, randomized, open-label extension of the PIONEER 7 trial
Long-term efficacy and safety of tirzepatide in participants with type 2 diabetes with inadequate glycaemic control on metformin and/or sulfonylurea: Post-hoc analysis of SURPASS-4
Mass spectral and theoretical investigations of the transient proton-bound dimers on the cleavage processes of the peptide GHK and its analogues
Middle-aged mice treated with GHK-Cu peptide administered intraperitoneally or intranasally show behavioral rescue but divergent hippocampal aging programs
Modulation of the interaction between G-actin and thymosin β4 by the ATP/ADP ratio: Possible implication in the regulation of actin dynamics
Modulatory effects of BPC 157 on vasomotor tone and the activation of Src‑Caveolin‑1‑endothelial nitric oxide synthase pathway
Neuronal M3 muscarinic acetylcholine receptors are essential for somatotroph proliferation and normal somatic growth
Novel Antioxidant Collagen Peptides of Siberian Sturgeon (Acipenser baerii) Cartilages: The Preparation, Characterization, and Cytoprotection of H2O2-Damaged Human Umbilical Vein Endothelial Cells (HUVECs
Novel Therapeutic Effects in Rat Spinal Cord Injuries: Recovery of the Definitive and Early Spinal Cord Injury by the Administration of Pentadecapeptide BPC 157 Therapy
Occluded Superior Mesenteric Artery and Vein. Therapy with the Stable Gastric Pentadecapeptide BPC 157
- Population
- Rat
- Finding and limits
- The investigators reported collateral-vessel recruitment and reduced pressure disturbances after mesenteric vessel ligation. This acute surgical rat experiment cannot establish a clinical vascular treatment.
Relevant PDF pages: 8.
Occlusion of the Superior Mesenteric Artery in Rats Reversed by Collateral Pathways Activation: Gastric Pentadecapeptide BPC 157 Therapy Counteracts Multiple Organ Dysfunction Syndrome; Intracranial, Portal, and Caval Hypertension; and Aortal Hypotension
Once‑weekly IcoSema versus once‑weekly semaglutide in adults with type 2 diabetes: the COMBINE 2 randomised clinical trial
Once-weekly semaglutide in people with HIV-associated lipohypertrophy: a randomised, double-blind, placebo-controlled phase IIb single-centred clinical trial
Oral Collagen Peptides and Vulvovaginal Radiofrequency Therapy for Genitourinary Syndrome of Menopause: A Pilot Randomized Study
Oral Intake of Low-Molecular-Weight Collagen Peptide Improves Hydration, Elasticity, and Wrinkling in Human Skin: A Randomized, Double-Blind, Placebo-Controlled Study
Oral Semaglutide and Cardiovascular Outcomes in People With Type 2 Diabetes, According to SGLT2i Use: Prespecified Analyses of the SOUL Randomized Trial
Oral semaglutide for Alcohol Use Disorder: A randomized clinical trial
Oral Supplementation of Specific Collagen Peptides Combined with Calf-Strengthening Exercises Enhances Function and Reduces Pain in Achilles Tendinopathy Patients
Oral administration of hydrolyzed collagen alleviates pain and enhances functionality in knee osteoarthritis: Results from a randomized, double-blind, placebo-controlled study
Over-Dose Lithium Toxicity as an Occlusive-like Syndrome in Rats and Gastric Pentadecapeptide BPC 157
PEGylated thymosin β4 is a thiol-site-specific prodrug treating myocardial infarction in vivo
Pentadecapeptide BPC 157 Reduces Bleeding and Thrombocytopenia after Amputation in Rats Treated with Heparin, Warfarin, L-NAME and L-Arginine
Pentadecapeptide BPC 157 Enhances the Growth Hormone Receptor Expression in Tendon Fibroblasts
- Population
- Rat-derived Achilles tendon fibroblasts
- Finding and limits
- BPC-157 increased growth-hormone receptor expression in cultured rat tendon fibroblasts. Receptor expression in a culture does not demonstrate higher circulating growth hormone in people.
Relevant PDF pages: 3.
Pentadecapeptide BPC 157 resolves Pringle maneuver in rats, both ischemia and reperfusion
Pentadecapeptide BPC 157 resolves suprahepatic occlusion of the inferior caval vein, Budd-Chiari syndrome model in rats
- Population
- Rat
- Finding and limits
- The investigators reported smaller clots and less ascites after experimental vena-cava obstruction. These results do not establish human liver-disease treatment or anticoagulant compatibility.
Relevant PDF pages: 6.
People With Lowest Physical Functioning Scores Showed Greatest Improvement After Tirzepatide Treatment
Pharmacokinetics, Safety and Tolerability of Once- Weekly Subcutaneous Semaglutide in Healthy Chinese Subjects: A Double-Blind, Phase 1, Randomized Controlled Trial
Pharmacokinetics, distribution, metabolism, and excretion of body-protective compound 157, a potential drug for treating various wounds, in rats and dogs
- Population
- Rat and dog
- Finding and limits
- Reported mean half-lives of intact BPC-157 were below thirty minutes in the tested rat and dog regimens. These findings do not establish a human half-life or dosing interval.
Relevant PDF pages: 2, 13.
Probing for peptidic drugs (2–10 kDa) in doping control blood samples
Prolonged Collagen Peptide Supplementation and Resistance Exercise Training Affects Body Composition in Recreationally Active Men
Protective Effects of BPC 157 on Liver, Kidney, and Lung Distant Organ Damage in Rats with Experimental Lower-Extremity Ischemia–Reperfusion Injury
Protective effects of BPC 157 in rats with experimentally induced lower extremity ischemia-reperfusion injury
Protective effects of pentadecapeptide BPC 157 on gastric ulcer in rats
- Population
- Rat
- Finding and limits
- BPC-157 reduced ulcer area in chemically or surgically induced rat gastric-injury models. The paper contains inconsistent comparator dose units and does not establish benefit for human digestive conditions.
Relevant PDF pages: 2.
Qualitative identification of growth hormone-releasing hormones in human plasma by means of immunoaffinity purification and LC-HRMS/MS
RGN-259 (thymosin β4) improves clinically important dry eye efficacies in comparison with prescription drugs in a dry eye model
Recombinant Human Thymosin β4 Attenuates Endotoxemia-Induced ALI and EAE by Suppressing Inflammatory and Oxidative Responses
Recombinant Human Thymosin β4 (rhTβ4) Modulates the Anti-Inflammatory Responses to Alleviate Benzalkonium Chloride (BAC)-Induced Dry Eye Disease
Recombinant Human Thymosin Beta-4 Protects against Mouse Coronavirus Infection
Recombinant human Thymosin β4 ameliorates experimental colitis and intestinal fibrosis through suppression of mineralocorticoid receptor signaling
Recombinant human thymosin beta-4 (rhTβ4) improved scalp condition and microbiome homeostasis in seborrheic dermatitis
Relationship Between Metabolic and Histological Responses in People With Metabolic Dysfunction–Associated Steatohepatitis With and Without Type 2 Diabetes: Participant-Level Exploratory Analysis of the SYNERGY-NASH Trial With Tirzepatide
Reparative Outcomes in Corneal Infection: Linking Adjunctive Tβ4 Treatment to Nerve Regeneration and Visual Function
Robert’s Intragastric Alcohol-Induced Gastric Lesion Model as an Escalated General Peripheral and Central Syndrome, Counteracted by the Stable Gastric Pentadecapeptide BPC 157
- Population
- Rat
- Finding and limits
- The investigators reported less gastric damage after concentrated alcohol injury in rats. The thirty-minute model does not establish protection from drinking alcohol in people.
Relevant PDF pages: 8.
Safety and efficacy of once-weekly semaglutide vs additional oral antidiabetic drugs in Japanese people with inadequately controlled type 2 diabetes: A randomized trial
Safety and efficacy of semaglutide once weekly vs sitagliptin once daily, both as monotherapy in Japanese people with type 2 diabetes
Safety and efficacy of switching from dulaglutide to tirzepatide across clinically relevant baseline characteristics in participants with T2D: subgroup analysis of SURPASS- SWITCH
Safety of Intravenous Infusion of BPC157 in Humans: A Pilot Study
- Population
- Human
- Finding and limits
- Two previously exposed adults underwent three days of laboratory and symptom monitoring, with no adverse effects reported by the authors. This was not a pharmacokinetic study and cannot establish long-term safety.
Relevant PDF pages: 4, 2.
Salutary effect of gastric pentadecapeptide BPC 157 in two different stress urinary incontinence models in female rats
Semaglutide Effects on Insulin Sensitivity and β-Cell Function in Patients With Schizophrenia, Prediabetes, and Obesity Treated With Second-Generation Antipsychotics: Findings From the HISTORI Trial, a 30-Week Randomized, Placebo-Controlled Trial With Semaglutide 1.0 mg Weekly
Semaglutide Injection Once-Weekly for Weight Management in Adults: Results From A Randomized Phase III, Active-Controlled Study
Semaglutide Injection in Indian Patients With Type 2 Diabetes Mellitus: A Randomised, Phase III, Active-Controlled Study
Semaglutide as a therapeutic option for elderly patients with type 2 diabetes: Pooled analysis of the SUSTAIN 1-5 trials
Semaglutide improves postprandial glucose and lipid metabolism, and delays first-hour gastric emptying in subjects with obesity
Once-Weekly Semaglutide in Adults with Overweight or Obesity
Semaglutide versus placebo in individuals with poor weight loss after bariatric surgery: a double-blinded, randomized, placebo-controlled trial
Serum thymosin β4 levels in patients with hepatitis B virusrelated liver failure
Shifts in waist-to-height ratio categories within tirzepatide groups: a post-hoc analysis of SURMOUNT-1
Significance of Thymosin β4 and Implication of PINCH-1-ILK-α-Parvin (PIP) Complex in Human Dilated Cardiomyopathy
Skin Anti-Aging and Moisturizing Effects of Low-Molecular-Weight Collagen Peptide Supplementation in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Skin Antiageing and Systemic Redox Effects of Supplementation with Marine Collagen Peptides and Plant-Derived Antioxidants: A Single-Blind Case-Control Clinical Study
Specific Collagen Peptides Improve Bone Mineral Density and Bone Markers in Postmenopausal Women—A Randomized Controlled Study
Specific Collagen Peptides in Combination with Resistance Training Improve Body Composition and Regional Muscle Strength in Premenopausal Women: A Randomized Controlled Trial
Specific collagen peptides supplementation increases collagen type I content in skeletal muscle after 12 weeks of high-load resistance training: a randomized controlled trial
Stable Gastric Pentadecapeptide BPC 157 May Counteract Myocardial Infarction Induced by Isoprenaline in Rats
Stable Gastric Pentadecapeptide BPC 157 Therapy for Monocrotaline-Induced Pulmonary Hypertension in Rats Leads to Prevention and Reversal
- Population
- Rat
- Finding and limits
- The investigators reported improvements after early and delayed treatment in monocrotaline-induced pulmonary hypertension. The findings do not establish a treatment for human pulmonary hypertension.
Relevant PDF pages: 5.
Stable Gastric Pentadecapeptide BPC 157 Therapy for Primary Abdominal Compartment Syndrome in Rats
- Population
- Rat
- Finding and limits
- BPC-157 reduced pressure disturbances and organ injury in acute rat experiments. The acute animal model and conflicting exposure-duration descriptions limit interpretation.
Relevant PDF pages: 7, 6.
Stable Gastric Pentadecapeptide BPC 157 Therapy of Rat Glaucoma
Stable Gastric Pentadecapeptide BPC 157 as a Therapy for the Disable Myotendinous Junctions in Rats
- Population
- Male Wistar rats
- Finding and limits
- The investigators reported functional and muscle-size recovery after separating the muscle–tendon junction in rats. This surgical model does not establish recovery from human sports injuries.
Relevant PDF pages: 7, 11.
Stable Isotope Labeling-Based Nontargeted Strategy for Characterization of the In Vitro Metabolic Profile of a Novel Doping BPC-157 in Doping Control by UHPLC-HRMS
Stable gastric pentadecapeptide BPC 157 can improve the healing course of spinal cord injury and lead to functional recovery in rats
Stable gastric pentadecapeptide BPC 157 in the treatment of colitis and ischemia and reperfusion in rats: New insights
Structural basis of actin sequestration by thymosin-β4: implications for WH2 proteins
Sustainability-oriented recovery of antioxidant and ACE-inhibitory low-molecular-weight peptide fractions from Thunnus albacares by-products via enzymatic hydrolysis and membrane ultrafiltration
Synthesis of thymosin β4 by peritoneal macrophages and adherent spleen cells
The Effect of Carbetocin on Cardiac Repolarization: A Randomized, Placebo- and Positive-Controlled QT/QTc Study in Healthy Adults
The Effect of the Human Peptide GHK on Gene Expression Relevant to Nervous System Function and Cognitive Decline
The Effects of Ingesting a Single Bolus of Hydrolyzed Collagen versus Free Amino Acids on Muscle Connective Protein Synthesis Rates
The Influence of Specific Bioactive Collagen Peptides on Body Composition and Muscle Strength in Middle-Aged, Untrained Men: A Randomized Controlled Trial
The Influence of Specific Bioactive Collagen Peptides on Knee Joint Discomfort in Young Physically Active Adults: A Randomized Controlled Trial
The Laccase-like Property of GHK-Cu and Its Applications in Colorimetric Sensing of Phenolic Compounds
The Sustained Effects of Bioactive Collagen Peptides on Skin Health: A Randomized, Double-Blind, Placebo-Controlled Clinical Study
The anti-nociceptive effect of BPC-157 on the incisional pain model in rats
The Control of Actin Nucleotide Exchange by Thymosin β4 and Profilin. A Potential Regulatory Mechanism for Actin Polymerization in Cells
The copper(II)-binding tripeptide GHK, a valuable crystallization and phasing tag for macromolecular crystallography
The dual glucose-dependent insulinotropic peptide and glucagon-like peptide-1 receptor agonist, tirzepatide, improves lipoprotein biomarkers associated with insulin resistance and cardiovascular risk in patients with type 2 diabetes
The effect of pentadecapeptide BPC 157 on hippocampal ischemia/reperfusion injuries in rats
The effect of specific bioactive collagen peptides on function and muscle remodeling during human resistance training
The effects of collagen peptide supplementation on appetite and post-exercise energy intake in females: a randomised controlled trial
The effects of oxytocin and carbetocin on hemostatic parameters in women after spontaneous vaginal delivery: a randomized trial
The glycyl-l-histidyl-l-lysine-Cu2+ tripeptide complex attenuates lung inflammation and fibrosis in silicosis by targeting peroxiredoxin 6
The naturally occurring peptide GHK reverses age-related fibrosis by modulating myofibroblast function
The tri-peptide GHK-Cu complex ameliorates lipopolysaccharideinduced acute lung injury in mice
Therapy Effect of the Stable Gastric Pentadecapeptide BPC 157 on Acute Pancreatitis as Vascular Failure-Induced Severe Peripheral and Central Syndrome in Rats
Thymosin β4-Enhancing Therapeutic Efficacy of Human Adipose-Derived Stem Cells in Mouse Ischemic Hindlimb Model
Thymosin β4 Is an Endogenous Iron Chelator and Molecular Switcher of Ferroptosis
Thymosin β4 Prevents Oxidative Stress, Inflammation, and Fibrosis in Ethanol- and LPS-Induced Liver Injury in Mice
Thymosin β4 Regulates Focal Adhesion Formation in Human Melanoma Cells and Affects Their Migration and Invasion
Thymosin β4 alleviates renal fibrosis and tubular cell apoptosis through TGF-β pathway inhibition in UUO rat models
Thymosin β4 increases cardiac cell proliferation, cell engraftment, and the reparative potency of human induced-pluripotent stem cell–derived cardiomyocytes in a porcine model of acute myocardial infarction
Thymosin β-4 is a novel regulator for primary cilium formation by nephronophthisis 3 in HeLa human cervical cancer cells
Thymosin-β4 prevents cardiac rupture and improves cardiac function in mice with myocardial infarction
Thymosin β4 reverses phenotypic polarization of glial cells and cognitive impairment via negative regulation of NF- κB signaling axis in APP/PS1 mice
Thymosin β4-sulfoxide attenuates inflammatory cell infiltration and promotes cardiac wound healing
Thymosin Beta-4 Suppresses Osteoclastic Differentiation and Inflammatory Responses in Human Periodontal Ligament Cells
Thymosin-β4 Regulates Motility and Metastasis of Malignant Mouse Fibrosarcoma Cells
Thymosin β4 (Fx peptide) is a potent regulator of actin polymerization in living cells
Thymosin β4: A ubiquitous peptide in rat and mouse tissues
Thymosin beta 4 as an Alzheimer disease intervention target identified using human brain organoids
Thymosin beta‑4 improves endothelial function and reparative potency of diabetic endothelial cells differentiated from patient induced pluripotent stem cells
Thymosin beta 4 ophthalmic solution for dry eye: a randomized, placebo-controlled, Phase II clinical trial conducted using the controlled adverse environment (CAE™) model
Thymosin β4 Sequesters the Majority of G-actin in Resting Human Polymorphonuclear Leukocytes
Time to weight plateau with tirzepatide treatment in the SURMOUNT-1 and SURMOUNT-4 clinical trials
Tirzepatide Associated With Reduced Albuminuria in Participants With Type 2 Diabetes: Pooled Post Hoc Analysis From the Randomized Active- and Placebo-Controlled SURPASS-1–5 Clinical Trials
Tirzepatide Efficacy and Tolerability According to Early Weight Response: A Post Hoc Analysis of the SURMOUNT-1 and SURMOUNT-2 Trials
Tirzepatide Treatment and Associated Changes in β-Cell Function and Insulin Sensitivity in People With Obesity or Overweight With Prediabetes or Normoglycemia: A Post Hoc Analysis From the SURMOUNT-1 Trial
Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial
Tirzepatide and health-related quality of life in adults with obesity or overweight: Results from the SURMOUNT-3 phase 3 randomized trial
Tirzepatide for sleep-disordered breathing in SURMOUNT-OSA: Time course and association with body weight
Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity
Tirzepatide in Adults With Type 1 Diabetes: A Phase 2 Randomized Placebo-Controlled Clinical Trial
Tirzepatide on ingestive behavior in adults with overweight or obesity: a randomized 6-week phase 1 trial
Tirzepatide on obstructive sleep apnea-related cardiometabolic risk: secondary outcomes of the SURMOUNT-OSA randomized trial
Tracheocutaneous Fistula Resolved by Pentadecapeptide BPC 157 Therapy Through the NO-System—Triple NO-Agent Approach in Rats
Weight reduction over time in tirzepatide-treated participants by early weight loss response: Post hoc analysis in SURMOUNT-1
Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension
Whey protein but not collagen peptides stimulate acute and longer-term muscle protein synthesis with and without resistance exercise in healthy older women: a randomized controlled trial
Effects of 12 Weeks of Hypertrophy Resistance Exercise Training Combined with Collagen Peptide Supplementation on the Skeletal Muscle Proteome in Recreationally Active Men
evoke and evoke+: design of two largescale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomatic Alzheimer’s disease
Oral supplementation with fish cartilage hydrolysate in an adult population suffering from knee pain and function discomfort: results from an innovative approach combining an exploratory clinical study and an ex vivo clinical investigation
ACE inhibitory casein peptide lowers blood pressure and reshapes gut microbiota in a randomized double blind placebo controlled trial
APD2: the updated antimicrobial peptide database and its application in peptide design
APD3: the antimicrobial peptide database as a tool for research and education
A Double-Blind, Randomized, Placebo-Controlled Crossover Clinical Study of the Effects of Alpha-s1 Casein Hydrolysate on Sleep Disturbance
A Multifunctional Peptide From Bacillus Fermented Soybean for Effective Inhibition of SARS-CoV-2 S1 Receptor Binding Domain and Modulation of Toll Like Receptor 4: A Molecular Docking Study
A Novel Peptide from Soybean Protein Isolate Significantly Enhances Resistance of the Organism under Oxidative Stress
A Potential Peptide From Soy Cheese Produced Using Lactobacillus delbrueckii WS4 for Effective Inhibition of SARS-CoV-2 Main Protease and S1 Glycoprotein
A casein hydrolysate based formulation attenuates obesity and associated nonalcoholic fatty liver disease and atherosclerosis in LDLr-/-.Leiden mice
A fish protein hydrolysate alters fatty acid composition in liver and adipose tissue and increases plasma carnitine levels in a mouse model of chronic inflammation
A randomised trial of carbetocin versus syntometrine in the management of the third stage of labour
A randomized double blind comparison of atosiban in patients with recurrent implantation failure undergoing IVF treatment
A Salmon Protein Hydrolysate Exerts Lipid-Independent Anti-Atherosclerotic Activity in ApoE-Deficient Mice
A second dose of kisspeptin-54 improves oocyte maturation in women at high risk of ovarian hyperstimulation syndrome: a Phase 2 randomized controlled trial
A soy protein Lunasin can ameliorate amyloid-beta 42 mediated neurodegeneration in Drosophila eye
A synthetic kisspeptin analog that triggers ovulation and advances puberty
Activation of the Melanocortin-1 Receptor by NDP-MSH Attenuates Oxidative Stress and Neuronal Apoptosis through PI3K/Akt/Nrf2 Pathway after Intracerebral Hemorrhage in Mice
Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial
Administration of bovine casein-derived peptide prevents cognitive decline in Alzheimer disease model mice
Adverse Effects of Carbetocin versus Oxytocin in the Prevention of Postpartum Haemorrhage after Caesarean Section: A Randomized Controlled Trial
Afamelanotide Is Associated with Dose-Dependent Protective Effect from Liver Damage Related to Erythropoietic Protoporphyria
Afamelanotide for Treatment of the Protoporphyrias: Impact on Quality of Life and Laboratory Parameters in a US Cohort
Agouti protein, mahogunin, and attractin in pheomelanogenesis and melanoblast-like alteration of melanocytes: a cAMP-independent pathway
Alleviating Effects of Black Soybean Peptide on Oxidative Stress Injury Induced by Lead in PC12 Cells via Keap1/Nrf2/TXNIP Signaling Pathway
Anti-Inflammatory and Antioxidant Properties of Casein Hydrolysate Produced Using High Hydrostatic Pressure Combined with Proteolytic Enzymes
Anti-inflammatory effects of a casein hydrolysate and its peptide-enriched fractions on TNFa-challenged Caco-2 cells and LPS-challenged porcine colonic explants
Antimicrobial peptide, cLF36, affects performance and intestinal morphology, microflora, junctional proteins, and immune cells in broilers challenged with E. coli
Antioxidant and Antiproliferative Activities of Heated Sterilized Pepsin Hydrolysate Derived from Half-Fin Anchovy (Setipinna taty
Behavioral effects of multiple-dose oxytocin treatment in autism: a randomized, placebo-controlled trial with long-term follow-up
Beyond pigmentation: signs of liver protection during afamelanotide treatment in Swiss patients with erythropoietic protoporphyria, an observational study
Bioactive Peptide Fractions from Collagen Hydrolysate of Common Carp Fish Byproduct: Antioxidant and Functional Properties
Brain-transportable soy dipeptide, Tyr-Pro, attenuates amyloid β peptide25-35-induced memory impairment in mice
Bryophyllum pinnatum enhances the inhibitory effect of atosiban and nifedipine on human myometrial contractility: an in vitro study
Calcium-binding properties, stability, and osteogenic ability of phosphorylated soy peptide-calcium chelate
Carbetocin in comparison with oxytocin in several dosing regimens for the prevention of uterine atony after elective caesarean section in the Netherlands
Carbetocin is a Functional Selective Gq Agonist That Does Not Promote Oxytocin Receptor Recycling After Inducing b-Arrestin-Independent Internalisation
Carbetocin versus oxytocin in the management of the third stage of labor for preventing postpartum hemorrhage after vaginal delivery
Carbetocin versus oxytocin with or without tranexamic acid for preventing postpartum hemorrhage in cesarean delivery: a randomized controlled trial
Carbetocin vs. Syntometrine in Prevention of Postpartum Hemorrhage: a Double Blind Randomized Control Trial
Cardiovascular Risk Reduction With Liraglutide: An Exploratory Mediation Analysis of the LEADER Trial
Characterization and Antioxidant Activity of Products Derived from Xylose–Bovine Casein Hydrolysate Maillard Reaction: Impact of Reaction Time
Characterization of casein hydrolysates derived from enzymatic hydrolysis
Commercial processed soy-based food product contains glycated and glycoxidated lunasin proteoforms
Comparison of Oxytocin vs. Carbetocin Uterotonic Activity after Caesarean Delivery Assessed by Electrohysterography: A Randomised Trial
Cost effectiveness analysis of carbetocin during cesarean section in a high volume maternity unit
Cost-effectiveness analysis of carbetocin for prevention of postpartum hemorrhage in a low-burden high-resource city of China
Cost‑effectiveness and budget impact of heat‑stable carbetocin compared to oxytocin and misoprostol for the prevention of postpartum hemorrhage (PPH) in women giving birth in India
DURATION-1: Exenatide Once Weekly Produces Sustained Glycemic Control and Weight Loss Over 52 Weeks
DURATION-2: efficacy and safety of switching from maximum daily sitagliptin or pioglitazone to once-weekly exenatide
Dapagliflozin once-daily and exenatide once-weekly dual therapy: A 24-week randomized, placebo-controlled, phase II study examining effects on body weight and prediabetes in obese adults without diabetes
Deep learning improves antimicrobial peptide recognition
Delineating tesamorelin response pathways in HIV‑associated NAFLD using a targeted proteomic and transcriptomic approach
Development and stability of a heat‐stable formulation of carbetocin for the prevention of postpartum haemorrhage for use in low and middle‐income countries
Development of a Soy Protein Hydrolysate with an Antihypertensive Effect
Dietary tuna hydrolysate modulates growth performance, immune response, intestinal morphology and resistance to Streptococcus iniae in juvenile barramundi, Lates calcarifer
Differential Effects of Oxytocin Receptor Antagonists, Atosiban and Nolasiban, on Oxytocin Receptor–Mediated Signaling in Human Amnion and Myometrium
Direct comparison of the effects of intravenous kisspeptin-10, kisspeptin-54 and GnRH on gonadotrophin secretion in healthy men
Selected passages
Analytical methods Serum LH and FSH levels were measured at all time points using automated chemiluminescent immunoassays (Abbott Diagnostics, Maidenhead, UK).
Direct_comparison_of_the_effects_of_intravenous_kisspeptin_10_kisspeptin_26089302_PMC4507333.pdf · PDF page 4
A single-blinded 3 h continuous intravenous infusion of gelofusin (vehicle), kisspeptin-10 (0.10, 0.30 or 1.00 nmol/kg/h), kisspeptin-54 (0.10, 0.30 or 1.00 nmol/ kg/h) or GnRH (0.10, 0.30 or 1.00 nmol/kg/h) was commenced at time 60 min and continued until 240 min (n = 5 subjects per group; see Table II for dose allocation of subjects).
Direct_comparison_of_the_effects_of_intravenous_kisspeptin_10_kisspeptin_26089302_PMC4507333.pdf · PDF page 3
main results and the role of chance: Serum LH and FSH levels were ∼3-fold higher during GnRH infusion when compared with kisspeptin-10 and ∼2-fold higher when compared with kisspeptin-54 [mean area under the curve serum LH during infusion (in hours times international units per litre, h.IU/l): 10.81 ± 1.73, 1.0 nmol/kg/h kisspeptin-10; 14.43 ± 1.27, 1.0 nmol/kg/h kisspeptin-54; 34.06 ± 5.18, 1.0 nmol/kg/h GnRH, P < 0.001 versus kisspeptin-10, P < 0.01 versus kisspeptin-54].
Direct_comparison_of_the_effects_of_intravenous_kisspeptin_10_kisspeptin_26089302_PMC4507333.pdf · PDF page 1
Dose-dependent social-cognitive effects of intranasal oxytocin delivered with novel Breath Powered device in adults with autism spectrum disorder: a randomized placebo-controlled double-blind crossover trial
Economic evaluation of carbetocin as prophylaxis for postpartum hemorrhage in the Philippines
Effect of Alpha-S1-Casein Tryptic Hydrolysate and L-Theanine on Poor Sleep Quality: A Double Blind, Randomized Placebo-Controlled Crossover Trial
Effect of a cod protein hydrolysate on postprandial glucose metabolism in healthy subjects: a double-blind cross-over trial
Effect of exenatide on heart rate and blood pressure in subjects with type 2 diabetes mellitus: a double-blind, placebo-controlled, randomized pilot study
Effect of fluoride varnish with added casein phosphopeptide-amorphous calcium phosphate on the acid resistance of the primary enamel
Effect of intensive application of self-assembling peptide P11-4 with fluoride, casein phosphopeptide amorphous calcium phosphate fluoride and sodium fluoride on streptococcus mutans level in preschool children: a randomized controlled clinical trial
Effect of liraglutide 3.0mg in individuals with obesity and moderate or severe obstructive sleep apnea: the SCALE Sleep Apnea randomized clinical trial
Effect of liraglutide on cardiac function in patients with type 2 diabetes mellitus: randomized placebo‑controlled trial
Effect of renal impairment on the pharmacokinetics of exenatide
Effect of small molecular weight soybean proteinderived peptide supplementation on attenuating burn injury-induced inflammation and accelerating wound healing in a rat model
Effect of the Casein-Derived Peptide Met-Lys-Pro on Cognitive Function in Community-Dwelling Adults Without Dementia: A Randomized, Double-Blind, Placebo-Controlled Trial
Effect of the Glucagon-Like Peptide-1 Receptor Agonists Semaglutide and Liraglutide on Kidney Outcomes in Patients With Type 2 Diabetes: Pooled Analysis of SUSTAIN 6 and LEADER
Effect of the casein phosphopeptideamorphous calcium phosphate fluoride (CPP- ACPF) and photobiomodulation (PBM) on dental hypersensitivity: A randomized controlled clinical trial
Effect of tracheal antimicrobial peptide on the development of Mannheimia haemolytica pneumonia in cattle
Effects of 6‑month treatment with the glucagon like peptide‑1 analogue liraglutide on arterial stiffness, left ventricular myocardial deformation and oxidative stress in subjects with newly diagnosed type 2 diabetes
Effects of Casein- Derived Peptide Met-Lys-Pro on Systolic and Diastolic Blood Pressure: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study
Effects of Casein Hydrolysate Ingestion on Thermoregulatory Responses in Healthy Adults during Exercise in Heated Conditions: A Randomized Crossover Trial
Effects of Liraglutide Versus Placebo on Cardiovascular Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease
Effects of a Cod Protein Hydrolysate Supplement on Symptoms, Gut Integrity Markers and Fecal Fermentation in Patients with Irritable Bowel Syndrome
Effects of Exenatide Alone and in Combination With Daclizumab on -Cell Function in Long-Standing Type 1 Diabetes
Effects of Exenatide and Lifestyle Modification on Body Weight and Glucose Tolerance in Obese Subjects With and Without Pre-Diabetes
Effects of Exenatide on Measures of b-Cell Function After 3 Years in Metformin-Treated Patients With Type 2 Diabetes
Effects of Exenatide Plus Rosiglitazone on -Cell Function and Insulin Sensitivity in Subjects With Type 2 Diabetes on Metformin
Effects of Exenatide vs. Metformin on endothelial function in obese patients with pre-diabetes: a randomized trial
Effects of liraglutide, metformin and gliclazide on body composition in patients with both type 2 diabetes and non-alcoholic fatty liver disease: A randomized trial
Effects of multiple‑dose intranasal oxytocin administration on social responsiveness in children with autism: a randomized, placebo‑controlled trial
Effects of Oxytocin and Prosocial Behavior on Brain Responses to Direct and Vicariously Experienced Pain
Effects of route of administration on oxytocininduced changes in regional cerebral blood flow in humans
Effects of tesamorelin on hepatic transcriptomic signatures in HIV-associated NAFLD
Effects of the once-daily GLP-1 analog liraglutide on gastric emptying, glycemic parameters, appetite and energy metabolism in obese, non-diabetic adults
Effects of tocolysis with nifedipine or atosiban on child outcome: follow-up of the APOSTEL III trial
Efficacy and Safety of Liraglutide 3.0 mg in Individuals With Overweight or Obesity and Type 2 Diabetes Treated With Basal Insulin: The SCALE Insulin Randomized Controlled Trial
Efficacy and Safety Comparison of Liraglutide, Glimepiride, and Placebo, All in Combination With Metformin, in Type 2 Diabetes The LEAD (Liraglutide Effect and Action in Diabetes)-2 study
Efficacy and Safety of Exenatide Once Weekly Versus Metformin, Pioglitazone, and Sitagliptin Used as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4) A 26-week double-blind study
Efficacy and Safety of Lixisenatide Once Daily Versus Exenatide Twice Daily in Type 2 Diabetes Inadequately Controlled on Metformin A 24-week, randomized, open-label, active-controlled study (GetGoal-X
Efficacy and Safety of the Human Glucagon-Like Peptide-1 Analog Liraglutide in Combination With Metformin and Thiazolidinedione in Patients With Type 2 Diabetes (LEAD-4 MetTZD
Efficacy of Fluoride Varnish and Casein Phosphopeptide-Amorphous Calcium Phosphate for Remineralization of Primary Teeth: A Randomized Clinical Trial
Eight Collagen Peptides from Hydrolysate Fraction of Spanish Mackerel Skins: Isolation, Identification, and In Vitro Antioxidant Activity Evaluation
Electrophysiological and Morphological Evidence for Synchronized GnRH Pulse Generator Activity Among Kisspeptin/Neurokinin B/ Dynorphin A (KNDy) Neurons in Goats
Elevated cerebrospinal fluid and blood concentrations of oxytocin following its intranasal administration in humans
Exenatide Protects Against Glucoseand Lipid-Induced Endothelial Dysfunction: Evidence for Direct Vasodilation Effect of GLP-1 Receptor Agonists in Humans
Exenatide Affects Circulating Cardiovascular Risk Biomarkers Independently of Changes in Body Composition
Exenatide compared with long-acting insulin to achieve glycaemic control with minimal weight gain in patients with type 2 diabetes: results of the Helping Evaluate Exenatide in patients with diabetes compared with Long-Acting insulin (HEELA) study
Exenatide once weekly for alcohol use disorder investigated in a randomized, placebo-controlled clinical trial
First-in-Human Study of Merotocin, a Short-Acting Peptidic Oxytocin Receptor Agonist for Lactation Support
Fish Hydrolysate Supplementation Containing n-3 Long Chain Polyunsaturated Fatty Acids and Peptides Prevents LPS-Induced Neuroinflammation
Four Weeks of Treatment With Liraglutide Reduces Insulin Dose Without Loss of Glycemic Control in Type 1 Diabetic Patients With and Without Residual b-Cell Function
Further Improvement in Postprandial Glucose Control With Addition of Exenatide or Sitagliptin to Combination Therapy With Insulin Glargine and Metformin A proof-of-concept study
GPR43 mediates microbiota metabolite SCFA regulation of antimicrobial peptide expression in intestinal epithelial cells via activation of mTOR and STAT3
Gelatin and Antioxidant Peptides from Gelatin Hydrolysate of Skipjack Tuna (Katsuwonus pelamis) Scales: Preparation, Identification and Activity Evaluation
German Cohort Observational Study to Investigate the Short- and Long-Term Safety and Clinical Effectiveness of Afamelanotide 16 mg (SCENESSE) in Patients With Erythropoietic Protoporphyria (EPP
Gut microbiota varies by opioid use, circulating leptin and oxytocin in African American men with diabetes and high burden of chronic disease
Hypothalamic-Pituitary-Ovarian Axis Reactivation by Kisspeptin-10 in Hyperprolactinemic Women With Chronic Amenorrhea
Identification of soybean peptide leginsulin variants in different cultivars and their insulin-like activities
Improved treatment satisfaction and weight-related quality of life with exenatide once weekly or twice daily
Improvement of Postprandial Endothelial Function After a Single Dose of Exenatide in Individuals With Impaired Glucose Tolerance and Recent-Onset Type 2 Diabetes
In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Increased phototoxic burn tolerance time and quality of life in patients with erythropoietic protoporphyria treated with afamelanotide – a three years observational study
Increasing the Hindgut Carbohydrate/Protein Ratio by Cecal Infusion of Corn Starch or Casein Hydrolysate Drives Gut Microbiota-Related Bile Acid Metabolism To Stimulate Colonic Barrier Function
Influence of Amino Acid Compositions and Peptide Profiles on Antioxidant Capacities of Two Protein Hydrolysates from Skipjack Tuna (Katsuwonus pelamis) Dark Muscle
Intercepting the complement amplification loop through podocyte MC5R signaling ameliorates membranous nephropathy
Intramyometrial and intravenous oxytocin compared to intravenous carbetocin for prevention of postpartum hemorrhage in elective cesarean section—A quasi-randomized controlled phase IV non-inferiority interventional trial
Intranasal Oxytocin Enhances Connectivity in the Neural Circuitry Supporting Social Motivation and Social Perception in Children with Autism
Intranasal oxytocin enhances intrinsic corticostriatal functional connectivity in women
Intranasal oxytocin increases neural responses to social reward in post-traumatic stress disorder
Intranasal oxytocin reduces provoked symptoms in female patients with posttraumatic stress disorder despite exerting sympathomimetic and positive chronotropic effects in a randomized controlled trial
Isolation and Characterization of an Antibacterial Peptide Fraction from the Pepsin Hydrolysate of Half-Fin Anchovy (Setipinna taty
Isolation and identification of an antioxidant collagen peptide from skipjack tuna (Katsuwonus pelamis) bone
Isolation of antioxidant peptides from yak casein hydrolysate
Kisspeptin and GPR54 immunoreactivity in a cohort of 518 patients defines favourable prognosis and clear cell subtype in ovarian carcinoma
Kisspeptin and LH pulsatile temporal coupling in PCOS patients
Kisspeptin and RFRP-3 differentially regulate food intake and metabolic neuropeptides in the female desert jerboa
Kisspeptin and neurokinin B interactions in modulating gonadotropin secretion in women with polycystic ovary syndrome
Kisspeptin expression levels in patients with placenta previa A randomized trial
Kisspeptin modulates sexual and emotional brain processing in humans
Kisspeptin neurones in the posterodorsal medial amygdala modulate sexual partner preference and anxiety in male mice
Kisspeptin Restores Pulsatile LH Secretion in Patients with Neurokinin B Signaling Deficiencies: Physiological, Pathophysiological and Therapeutic Implications
Kisspeptin signaling in the amygdala modulates reproductive hormone secretion
Kisspeptin Signaling Is Required for the Luteinizing Hormone Response in Anestrous Ewes following the Introduction of Males
Kisspeptin Signalling in the Hypothalamic Arcuate Nucleus Regulates GnRH Pulse Generator Frequency in the Rat
Levels of the Novel Endogenous Antagonist of Ghrelin Receptor, Liver-Enriched Antimicrobial Peptide-2, in Patients with Rheumatoid Arthritis
Lipo-oxytocin-1, a Novel Oxytocin Analog Conjugated with Two Palmitoyl Groups, Has Long-Lasting Effects on Anxiety-Related Behavior and Social Avoidance in CD157 Knockout Mice
Liraglutide 3.0 mg and Intensive Behavioral Therapy (IBT) for Obesity in Primary Care: The SCALE IBT Randomized Controlled Trial
Liraglutide, Sitagliptin, and Insulin Glargine Added to Metformin: The Effect on Body Weight and Intrahepatic Lipid in Patients With Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease
Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU
Liraglutide, a once-daily human glucagon-like peptide 1 analogue, provides sustained improvements in glycaemic control and weight for 2 years as monotherapy compared with glimepiride in patients with type 2 diabetes
Liraglutide improves metabolic parameters and carotid intima‑media thickness in diabetic patients with the metabolic syndrome: an 18‑month prospective study
Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial
Low-dose oxytocin delivered intranasally with Breath Powered device affects social-cognitive behavior: a randomized fourway crossover trial with nasal cavity dimension assessment
MC1R is dispensable for the proteinuria reducing and glomerular protective effect of melanocortin therapy
Melanocortin receptor agonist NDP-a-MSH improves cognitive deficits and microgliosis but not amyloidosis in advanced stages of AD progression in 5XFAD and 3xTg mice
Mitogen- and stress-activated protein kinase-1 activation is involved in melanocortin-induced BDNF expression in Neuro2a neuronal cells
Modulations of human resting brain connectivity by kisspeptin enhance sexual and emotional functions
Molecular Basis of Resistance to Muramidase and Cationic Antimicrobial Peptide Activity of Lysozyme in Staphylococci
Multi-dimensional analysis of heat-induced soybean protein hydrolysate gels subjected to ultrasound-assisted pH pretreatment
NDP-MSH binding melanocortin-1 receptor ameliorates neuroinflammation and BBB disruption through CREB/Nr4a1/NF-κB pathway after intracerebral hemorrhage in mice
NDP-MSH rescues LPS-induced neuroinflammation, synaptic deficits, and depressive-like behaviors in mice: involvement of MC1R–cAMP/PKA signaling
Neuroanatomical Evidence That Kisspeptin Directly Regulates Isotocin and Vasotocin Neurons
New Bioactive Peptides Identified from a Tilapia Byproduct Hydrolysate Exerting Effects on DPP-IV Activity and Intestinal Hormones Regulation after Canine Gastrointestinal Simulated Digestion
Nifedipine versus atosiban in the treatment of threatened preterm labour (Assessment of Perinatal Outcome after Specific Tocolysis in Early Labour: APOSTEL III-Trial
Nle4, D-Phe7]-α-MSH Inhibits Toll-Like Receptor (TLR)2- and TLR4-Induced Microglial Activation and Promotes a M2-Like Phenotype
No Evidence that MDMA-Induced Enhancement of Emotional Empathy Is Related to Peripheral Oxytocin Levels or 5-HT1a Receptor Activation
Novel Soy Peptide CBP: Stimulation of Osteoblast Differentiation via TβRI-p38-MAPK-Depending RUNX2 Activation
Novel antimicrobial activities of a peptide derived from a Japanese soybean fermented food, Natto, against Streptococcus pneumoniae and Bacillus subtilis group strains
Nutty-like flavor production by Corynbacterium glutamicum 1220T from enzymatic soybean hydrolysate. Effect of encapsulation and storage on the nutty flavoring quality
Obesity-Related Metabolomic Analysis of Human Subjects in Black Soybean Peptide Intervention Study by Ultraperformance Liquid Chromatography and Quadrupole-Time-of-Flight Mass Spectrometry
One year of liraglutide treatment offers sustained and more effective glycaemic control and weight reduction compared with sitagliptin, both in combination with metformin, in patients with type 2 diabetes: a randomised, parallel-group, open-label trial
One-Year Treatment With Exenatide Improves -Cell Function, Compared With Insulin Glargine, in Metformin-Treated Type 2 Diabetic Patients A randomized, controlled trial
Optimization of Hydrolysis Conditions for the Production of Angiotensin-I Converting Enzyme-Inhibitory Peptides and Isolation of a Novel Peptide from Lizard Fish (Saurida elongata) Muscle Protein Hydrolysate
Oxidative Stress in Women Treated with Atosiban for Impending Preterm Birth
Oxytocin Receptor Antagonists, Atosiban and Nolasiban, Inhibit Prostaglandin F2α-induced Contractions and Inflammatory Responses in Human Myometrium
Oxytocin efficacy is modulated by dosage and oxytocin receptor genotype in young adults with high-functioning autism: a 24-week randomized clinical trial
Oxytocin increases eye contact during a real-time, naturalistic social interaction in males with and without autism
Oxytocin Increases Heart Rate Variability in Humans at Rest: Implications for Social Approach-Related Motivation and Capacity for Social Engagement
Oxytocin may be useful to increase trust in others and decrease disruptive behaviours in patients with Prader-Willi syndrome: a randomised placebo-controlled trial in 24 patients
Peripheral MC1R Activation Modulates Immune Responses and is Neuroprotective in a Mouse Model of Parkinson’s Disease
Pharmacodynamic characteristics of lixisenatide once daily versus liraglutide once daily in patients with type 2 diabetes insufficiently controlled on metformin
Placebo-controlled randomised trial with liraglutide on magnetic resonance endpoints in individuals with type 2 diabetes: a pre-specified secondary study on ectopic fat accumulation
Preclinical Melanoma Imaging with 68Ga-Labeled α-Melanocyte-Stimulating Hormone Derivatives Using PET
Preparation, Characterization, and Cytoprotective Effects on HUVECs of Fourteen Novel Angiotensin-I-Converting Enzyme Inhibitory Peptides From Protein Hydrolysate of Tuna Processing By-Products
Preparation, Characterization and In Vitro Stability of a Novel ACE-Inhibitory Peptide from Soybean Protein
Preparation, Identification, Molecular Docking Study and Protective Function on HUVECs of Novel ACE Inhibitory Peptides from Protein Hydrolysate of Skipjack Tuna Muscle
Preparation and Characterization of Gelatin and Antioxidant Peptides from Gelatin Hydrolysate of Skipjack Tuna (Katsuwonus pelamis) Bone Stimulated by in vitro Gastrointestinal Digestion
Preparation and functional evaluation of collagen oligopeptide-rich hydrolysate from fish skin with the serine collagenolytic protease from Pseudoalteromonas sp. SM9913
Probiotic and Oxytocin Combination Therapy in Patients with Autism Spectrum Disorder: A Randomized, Double-Blinded, Placebo-Controlled Pilot Trial
Production and Characterization of Medium-Sized and Short Antioxidant Peptides from Soy Flour-Simulated Gastrointestinal Hydrolysate
Prospective Activity of PLG0206, an Engineered Antimicrobial Peptide, on Chronic Periprosthetic Joint Infection Total Knee Arthroplasty Components Ex Vivo: The Knee Explant Analysis (KnEA) Study
Protective Effect of Tuna Bioactive Peptide on Dextran Sulfate Sodium-Induced Colitis in Mice
Protective potential of casein phosphopeptide amorphous calcium phosphate containing paste on enamel surfaces
Purification and Characterization of a Novel Calcium-Binding Heptapeptide from the Hydrolysate of Tilapia Bone with Its Osteogenic Activity
Recombinant Lactococcus lactis NZ9000 secretes a bioactive kisspeptin that inhibits proliferation and migration of human colon carcinoma HT‑29 cells
Reinforcing Lipid A Acylation on the Cell Surface of Acinetobacter baumannii Promotes Cationic Antimicrobial Peptide Resistance and Desiccation Survival
Remineralization of dentin slices using casein phosphopeptide–amorphous calcium phosphate combined with sodium tripolyphosphate
Remineralization of enamel subsurface lesions with casein phosphopeptide-amorphous calcium phosphate: A quantitative energy dispersive X-ray analysis using scanning electron microscopy: An in vitro study
Remineralization potential of bioactive glass and casein phosphopeptide-amorphous calcium phosphate on initial carious lesion: An in-vitro pH-cycling study
Remineralization potential of fluoride and amorphous calcium phosphate-casein phospho peptide on enamel lesions: An in vitro comparative evaluation
Restoring effects of oxytocin on the attentional preference for faces in autism
Robust Reductions of Body Weight and Food Intake by an Oxytocin Analog in Rats
Safety and metabolic effects of tesamorelin, a growth hormone-releasing factor analogue, in patients with type 2 diabetes: A randomized, placebo-controlled trial
Selected passages
The objective of this study was to determine whether tesamorelin, a stabilized growth hormonereleasing hormone analogue, would alter insulin sensitivity or control of diabetes.
Safety_and_metabolic_effects_of_tesamorelin_a_growth_hormone_releasing_f_28617838_PMC5472315.pdf · PDF page 1
Statistical analyses The primary endpoint of the study was the relative insulin response over the 12-week treatment period.
Safety_and_metabolic_effects_of_tesamorelin_a_growth_hormone_releasing_f_28617838_PMC5472315.pdf · PDF page 4
After screening and a 14-day lead-in period to establish and characterize daily dietary patterns and blood measurements, patients diabetes were randomly assigned to receive either placebo, tesamorelin 1 mg, or tesamorelin 2 mg, administered by subcutaneous injection for 12 weeks (Fig 1).
Safety_and_metabolic_effects_of_tesamorelin_a_growth_hormone_releasing_f_28617838_PMC5472315.pdf · PDF page 2
There was a borderline effect of time on fasting glucose (p = 0.06), with glucose values higher in the tesamorelin 2 mg group at Weeks 4 and 8 compared to values in the other groups.
Safety_and_metabolic_effects_of_tesamorelin_a_growth_hormone_releasing_f_28617838_PMC5472315.pdf · PDF page 8
Safety and tolerability of the antimicrobial peptide human lactoferrin 1-11 (hLF1-11
Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide
Salivary Oxytocin Concentrations in Males following Intranasal Administration of Oxytocin: A Double-Blind, Cross-Over Study
Scalable Purification and Characterization of the Anticancer Lunasin Peptide from Soybean
Screening of Novel Bioactive Peptides from Goat Casein: In Silico to In Vitro Validation
Self-RNA–antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8
Sequential Intensification of Metformin Treatment in Type 2 Diabetes With Liraglutide Followed by Randomized Addition of Basal Insulin Prompted by A1C Targets
Serum Stabilities of Short Tryptophan- and Arginine-Rich Antimicrobial Peptide Analogs
Sexual dimorphism of kisspeptin and neurokinin B immunoreactive neurons in the infundibular nucleus of aged men and women
Short-Term Exenatide Treatment Leads to Significant Weight Loss in a Subset of Obese Women Without Diabetes
Soybean protein-derived peptide nutriment increases negative nitrogen balance in burn injury-induced inflammatory stress response in aged rats through the modulation of white blood cells and immune factors
Structural and DNA-binding studies on the bovine antimicrobial peptide, indolicidin: evidence for multiple conformations involved in binding to membranes and DNA
Structure-function-guided exploration of the antimicrobial peptide polybia-CP identifies activity determinants and generates synthetic therapeutic candidates
Subcutaneous infusion of kisspeptin-54 stimulates gonadotrophin release in women and the response correlates with basal oestradiol levels
Supplementation with Low Doses of a Cod Protein Hydrolysate on Glucose Regulation and Lipid Metabolism in Adults with Metabolic Syndrome: A Randomized, Double-Blind Study
Supplementation with a fish protein hydrolysate (Micromesistius poutassou): effects on body weight, body composition, and CCK/GLP-1 secretion
Switching to Once-Daily Liraglutide From Twice-Daily Exenatide Further Improves Glycemic Control in Patients With Type 2 Diabetes Using Oral Agents
Targeting hepatic kisspeptin receptor ameliorates nonalcoholic fatty liver disease in a mouse model
The Alzheimer’s Disease-Associated Amyloid b-Protein Is an Antimicrobial Peptide
The Effect of Supplementation with Low Doses of a Cod Protein Hydrolysate on Satiety Hormones and Inflammatory Biomarkers in Adults with Metabolic Syndrome: A Randomized, Double-Blind Study
The Effects of Antimicrobial Peptide Nal-P-113 on Inhibiting Periodontal Pathogens and Improving Periodontal Status
THE GROWTH HORMONE RELEASING HORMONE ANALOGUE, TESAMORELIN, DECREASES MUSCLE FAT AND INCREASES MUSCLE AREA IN ADULTS WITH HIV
Selected passages
The goals of this exploratory secondary analysis were to determine the effects of tesamorelin on muscle quality, as measured by changes in computed tomography (CT)based trunk muscle density, a biopsy-correlated measurement of skeletal muscle fat (26), and trunk muscle area.
The_Growth_Hormone_Releasing_Hormone_Analogue_Tesamorelin_Decreases_Musc_31237318_PMC6766405.pdf · PDF page 2
The Impact of Oxytocin on Food Intake and Emotion Recognition in Patients with Eating Disorders: A Double Blind Single Dose Within- Subject Cross-Over Design
The Soybean Peptide Vglycin Preserves the Diabetic β-cells through Improvement of Proliferation and Inhibition of Apoptosis
The Synthetic Melanocortin Agonist NDP-MSH Ameliorates THSD7A-Associated Membranous Nephropathy in an Active Immunization Mouse Model
The anti-obesity effects of a tuna peptide on 3T3-L1 adipocytes are mediated by the inhibition of the expression of lipogenic and adipogenic genes and by the activation of the Wnt/β-catenin signaling pathway
The antimicrobial peptide ZY4 combats multidrugresistant Pseudomonas aeruginosa and Acinetobacter baumannii infection
The antimicrobial peptide thanatin disrupts the bacterial outer membrane and inactivates the NDM-1 metallo-β-lactamase
The Bacterial Defensin Resistance Protein MprF Consists of Separable Domains for Lipid Lysinylation and Antimicrobial Peptide Repulsion
The effect of GLP-1RA exenatide on idiopathic intracranial hypertension: a randomized clinical trial
The effect of growth hormone-releasing hormone on cognition and brain connectivity in adults with cognition ranging from normal to mild cognitive impairment
The effect of oxytocin nasal spray on social interaction deficits observed in young children with autism: a randomized clinical crossover trial
The effect of oxytocin nasal spray on social interaction in young children with autism: a randomized clinical trial
Selected passages
A total of 87 children (aged between 3 and 12 years) with autism received 16 International Units (IU) of oxytocin (n = 45) or placebo (n = 42) nasal spray, morning and night (32 IU per day) for twelve weeks, following a 3-week placebo lead-in phase.
The_effect_of_oxytocin_nasal_spray_on_social_interaction_in_young_childr_36302965_PMC9607840.pdf · PDF page 1
The first primary outcome measure was the caregivercompleted Social Responsiveness Scale, Second Edition (SRS-2) [24].
The_effect_of_oxytocin_nasal_spray_on_social_interaction_in_young_childr_36302965_PMC9607840.pdf · PDF page 2
Overall, there was no effect of oxytocin treatment over time on the caregiver-rated Social Responsiveness Scale (SRS-2) (p = 0.686). However, a significant interaction with age (p = 0.028) showed that for younger children, aged 3–5 years, there was some indication of a treatment effect. Younger children who received oxytocin showed improvement on caregiver-rated social responsiveness ( SRS-2). There was no other evidence of benefit in the sample as a whole, or in the younger age group, on the clinician-rated Clinical Global Improvement Scale (CGI-S), or any secondary measure.
The_effect_of_oxytocin_nasal_spray_on_social_interaction_in_young_childr_36302965_PMC9607840.pdf · PDF page 1
The effect of oxytocin on attention to angry and happy faces in chronic depression
The effects of kisspeptin on β-cell function, serum metabolites and appetite in humans
TheFateofTaspoglutide,aWeeklyGLP-1 Receptor Agonist, Versus Twice-Daily Exenatide for Type 2 Diabetes The T-emerge 2 trial
The oxytocin/vasopressin receptor antagonist atosiban delays the gastric emptying of a semisolid meal compared to saline in human
The soy-derived peptide Lunasin inhibits invasive potential of melanoma initiating cells
The soybean-derived peptide lunasin inhibits non-small cell lung cancer cell proliferation by suppressing phosphorylation of the retinoblastoma protein
The Vasoactive Potential of Kisspeptin-10 in the Peripheral Vasculature
Tolerability of nausea and vomiting and associations with weight loss in a randomized trial of liraglutide in obese, non-diabetic adults
Toll-like receptor and antimicrobial peptide expression in the bovine endometrium
Transcriptome profiling of kisspeptin neurons from the mouse arcuate nucleus reveals new mechanisms in estrogenic control of fertility
Transepithelial Transport Characteristics of the Cholesterol- Lowing Soybean Peptide, WGAPSL, in Caco-2 Cell Monolayers
Treatment of Obesity and Diabetes Using Oxytocin or Analogs in Patients and Mouse Models
Treatment with the Topical Antimicrobial Peptide Omiganan in Mild-to-Moderate Facial Seborrheic Dermatitis versus Ketoconazole and Placebo: Results of a Randomized Controlled Proof-of-Concept Trial
Twelve Antioxidant Peptides From Protein Hydrolysate of Skipjack Tuna (Katsuwonus pelamis) Roe Prepared by Flavourzyme: Purification, Sequence Identification, and Activity Evaluation
Twelve week liraglutide or sitagliptin does not affect hepatic fat in type 2 diabetes: a randomised placebo-controlled trial
Ultrasonication for production of nanoliposomes with encapsulated soy protein concentrate hydrolysate: Process optimization, vesicle characteristics and in vitro digestion
Unique profile of antimicrobial peptide expression in polymorphic light eruption lesions compared to healthy skin, atopic dermatitis, and psoriasis
Uropathogenic Escherichia coli Modulates Immune Responses and Its Curli Fimbriae Interact with the Antimicrobial Peptide LL-37
Expanded-access use of elamipretide in a patient with membrane protein-associated neurodegeneration
Expanded-Access Use of Elamipretide Improves Quality of Life in Patients With Rare Mitochondrial Disorders Characterized by Ophthalmic Symptoms: A Case Series
Unleashing the power of retatrutide: A possible triumph over obesity and overweight: A correspondence
A randomized crossover trial of elamipretide in adults with primary mitochondrial myopathy
Mitochondrial Adaptations in Skeletal Muscle Following Incretin-Based Therapies: In Vitro
Use of Elamipretide in patients assigned treatment in the compassionate use program: Case series in pediatric patients with rare orphan diseases
Semaglutide 2.4 mg for the Treatment of Obesity: Key Elements of the STEP Trials 1 to 5
Retatrutide Shows Multiple Metabolic Benefits in Diet-Induced Obese MASH Mouse and Hamster Models
Detection and Excretion Profile of Retatrutide in Human Plasma and Urine by LC-HRMS: Implications for Antidoping Analysis
Achilles tendon rupture healing is enhanced by intermittent pneumatic compression upregulating collagen type I synthesis
Contractile effects of retatrutide in isolated mouse atrial preparations
Efficacy of concentrated growth factor versus collagen membrane in reconstructive surgical therapy of peri‑implantitis: 3‑year results of a randomized clinical trial
Renal or Hepatic Impairment Does Not Affect Pharmacokinetics, Safety, or Tolerability of Subcutaneous Cagrilintide
The effects of whey, pea, and collagen protein supplementation beyond the recommended dietary allowance on integrated myofibrillar protein synthetic rates in older males: a randomized controlled trial
Cagrilintide lowers bodyweight through brain amylin receptors 1 and 3
The Effect of Retatrutide on Kidney Parameters in Participants With Type 2 Diabetes Mellitus and/or Obesity
Comparative effects of semaglutide tirzepatide and retatrutide on renal fibrosis in UUO and aged mice
Mitochondria dysfunction and increased expression of WNT5A and BNIP3 in tenocytes obtained from patients with tendinopathy
Eloralintide (LY3841136), a novel amylin receptor agonist for the treatment of obesity: From discovery to clinical proof of concept
Perceived benefits of treatment for obesity with retatrutide: A qualitative study of patients in a phase 2 clinical trial
Differentiation of human subcutaneous adipocytes and measurement of lipolytic function induced by GIP or LY3437943
Semax, a Synthetic Regulatory Peptide, Affects Copper-Induced Abeta Aggregation and Amyloid Formation in Artificial Membrane Models
Markers of type I collagen degradation and synthesis in the monitoring of treatment response in bone metastases from breast carcinoma
Efficacy of GLP-1 analog peptides, semaglutide, tirzepatide, and retatrutide on MC4R deficient obesity and their comparison
Structural insights into the triple agonism at GLP-1R, GIPR and GCGR manifested by retatrutide
A phase 2/3 randomized clinical trial followed by an open-label extension to evaluate the effectiveness of elamipretide in Barth syndrome, a genetic disorder of mitochondrial cardiolipin metabolism
Structural and dynamic features of cagrilintide binding to calcitonin and amylin receptors
Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial
Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial
Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial
Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial
Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial
Effects of tirzepatide on circulatory overload and end-organ damage in heart failure with preserved ejection fraction and obesity: a secondary analysis of the SUMMIT trial
Tirzepatide leads to weight reduction in people with obesity due to MC4R deficiency
Collagen fragments quantified in serum as measures of desmoplasia associate with survival outcome in patients with advanced pancreatic cancer
Effect of aerobic and resistance exercise on the mitochondrial peptide MOTS‑c in Hispanic and Non‑Hispanic White breast cancer survivors
CagriSema drives weight loss in rats by reducing energy intake and preserving energy expenditure
A cross-species atlas of the dorsal vagal complex reveals neural mediators of the effects of cagrilintide on energy balance
Distinct brain regions mediate regulation of food intake in response to GIPR agonism or antagonism
Incretin triple agonist retatrutide (LY3437943) alleviates obesityassociated cancer progression
Expanded-access use of elamipretide in a newborn with Barth syndrome: a case report
Rationale, design and baseline characteristics of the TRANSCEND-CKD trial of retatrutide in patients with chronic kidney disease
Polymerized-Type I Collagen Downregulates Inflammation and Improves Clinical Outcomes in Patients with Symptomatic Knee Osteoarthritis Following Arthroscopic Lavage: A Randomized, Double-Blind, and Placebo-Controlled Clinical Trial
Treatment with the mitochondrial-targeted antioxidant peptide SS-31 rescues neurovascular coupling responses and cerebrovascular endothelial function and improves cognition in aged mice
Randomised clinical trial: semaglutide versus placebo reduced liver steatosis but not liver stiffness in subjects with non-alcoholic fatty liver disease assessed by magnetic resonance imaging
Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity
Semaglutide, reduction in glycated haemoglobin and the risk of diabetic retinopathy
The effect of semaglutide 2.4 mg once weekly on energy intake, appetite, control of eating, and gastric emptying in adults with obesity
Gastrointestinal tolerability of once-weekly semaglutide 2.4 mg in adults with overweight or obesity, and the relationship between gastrointestinal adverse events and weight loss
Tirzepatide 10 and 15 mg versus semaglutide 2.4 mg in people with obesity or overweight with type 2 diabetes: An indirect treatment comparison
Decreases in circulating ANGPTL3/8 concentrations following retatrutide treatment parallel reductions in serum lipids
Association between patient-reported eating behaviours and weight change: Secondary analyses of a randomized, doubleblind trial comparing retatrutide and placebo in people with obesity or overweight
Appetite, eating attitudes, and eating behaviours during treatment with retatrutide in adults with type 2 diabetes: Results of a phase 2 study
Tirzepatide and the 10-year predicted risk of cardiovascular disease and type 2 diabetes in adults with obesity and prediabetes: A post hoc analysis from the three-year SURMOUNT-1 trial
Efficacy of CagriSema for Reaching Anthropometric Treatment Targets and Cardiometabolic Outcomes: A Secondary, Post hoc Analysis of REDEFINE 1
A randomized, triple-blind, placebo-controlled, parallel study to evaluate the efficacy of a freshwater marine collagen on skin wrinkles and elasticity
ROS-responsive chitosan-SS31 prodrug for AKI therapy via rapid distribution in the kidney and long-term retention in the renal tubule
Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV (TRIUMPH): a clinical trial protocol
Tirzepatide and blood pressure reduction: stratified analyses of the SURMOUNT-1 randomised controlled trial
Peptide Selank Enhances the Effect of Diazepam in Reducing Anxiety in Unpredictable Chronic Mild Stress Conditions in Rats
Semax, a Copper Chelator Peptide, Decreases the Cu(II)-Catalyzed ROS Production and Cytotoxicity of aβ by Metal Ion Stripping and Redox Silencing
CagriSema Reduces Blood Pressure in Adults With Overweight or Obesity: REDEFINE 1
Reduction of Ischemia/Reperfusion Injury With Bendavia, a Mitochondria-Targeting Cytoprotective Peptide
Effects of Glucagon-Like Peptide-1 Receptor Agonists, Sodium-Glucose Cotransporter-2 Inhibitors, and Their Combination on Neurohumoral and Mitochondrial Activation in Patients With Diabetes
Circulating Mitochondrial Open Reading Frame of the 12S Ribosomal RNA Type-c Is Higher in Acute Coronary Syndrome and Is a Prognostic Biomarker for Major Cardiac Events in Patients With Acute Myocardial Infarction: A Case–Control Study
Growth Hormone Secretagogue Treatment in Hypogonadal Men Raises Serum Insulin-Like Growth Factor-1 Levels
The peptide semax affects the expression of genes related to the immune and vascular systems in rat brain focal ischemia: genome-wide transcriptional analysis
A randomized, controlled study to investigate the efficacy and safety of a topical gentamicin-collagen sponge in combination with systemic antibiotic therapy in diabetic patients with a moderate or severe foot ulcer infection
Effects of graviola oil extract on fattening performance and circadian rhythms of adipokine, cardiac and mitochondrial function markers in lambs
LPA1 antagonist BMS‑986020 changes collagen dynamics and exerts antifibrotic effects in vitro and in patients with idiopathic pulmonary fibrosis
A possible role for mitochondrial‑derived peptides humanin and MOTS‑c in patients with Q fever fatigue syndrome and chronic fatigue syndrome
Elamipretide (SS-31) improves mitochondrial dysfunction, synaptic and memory impairment induced by lipopolysaccharide in mice
Natural history comparison study to assess the efficacy of elamipretide in patients with Barth syndrome
Identifying responders to elamipretide in Barth syndrome: Hierarchical clustering for time series data
Genotype‑specific effects of elamipretide in patients with primary mitochondrial myopathy: a post hoc analysis of the MMPOWER‑3 trial
Initial Psychometric Evaluation of the Barth Syndrome Symptom Assessment (BTHS‑SA) for Adolescents and Adults in a Phase 2 Clinical Study
Multi-omic profiling reveals Retatrutide alleviates adipose tissue fibrosis via metabolic reprogramming and tissue repair
Randomized dose-escalation trial of elamipretide in adults with primary mitochondrial myopathy
Efficacy and Safety of Elamipretide in Individuals With Primary Mitochondrial Myopathy The MMPOWER-3 Randomized Clinical Trial
Collagen Protein Ingestion during Recovery from Exercise Does Not Increase Muscle Connective Protein Synthesis Rates
Predictors of Treatment Response to Tesamorelin, a Growth Hormone-Releasing Factor Analog, in HIV-Infected Patients with Excess Abdominal Fat
Collagen Type III and VI Turnover in Response to Long-Term Immobilization
Age-related collagen turnover of the interstitial matrix and basement membrane: Implications of age- and sex-dependent remodeling of the extracellular matrix
In vivo mitochondrial ATP production is improved in older adult skeletal muscle after a single dose of elamipretide in a randomized trial
Combined antiretroviral therapy with low- or normal-protein, high-calorie diets appears to induce significant deleterious electrocardiographic changes in a rodent model
Circulating levels of MOTS-c in patients with breast cancer treated with metformin
A potentially effective drug for patients with recurrent glioma: sermorelin
Circulating PGC-1α and MOTS-c Peptide as Potential Mitochondrial Biomarkers in Patients Undergoing Aortic Valve Replacement
Predictors of Initial and Sustained Glycemic and Weight Response to Tirzepatide: A Post Hoc Analysis of SURPASS-4
Tirzepatide Reduces Appetite, Energy Intake, and Fat Mass in People With Type 2 Diabetes
Early-Onset Type 2 Diabetes and Tirzepatide Treatment: A Post Hoc Analysis From the SURPASS Clinical Trial Program
Estimating the True MACE Benefits From Tirzepatide in SURPASS-CVOT Using an Imputed Placebo Analysis of REWIND
Correction of Long-Lasting Negative Effects of Neonatal Isolation in White Rats Using Semax
A Mouse Model of Nigrostriatal Dopaminergic Axonal Degeneration As a Tool for Testing Neuroprotectors
The Potential of the Peptide Drug Semax and Its Derivative for Correcting Pathological Impairments in the Animal Model of Alzheimer’s Disease
SS-31 Peptide Reverses the Mitochondrial Fragmentation Present in Fibroblasts From Patients With DCMA, a Mitochondrial Cardiomyopathy
Analysis by Metabolomics and Transcriptomics for the Energy Metabolism Disorder and the Aryl Hydrocarbon Receptor Activation in Male Reproduction of Mice and GC- 2spd Cells Exposed to PM2.5
Selank Administration Affects the Expression of Some Genes Involved in GABAergic Neurotransmission
GABA, Selank, and Olanzapine Affect the Expression of Genes Involved in GABAergic Neurotransmission in IMR-32 Cells
Anterior cervical osteophyte-related dysphagia in a longterm growth hormone user: a case report
The Mitochondrial-Derived Peptide MOTS-c Alleviates Radiation Pneumonitis via an Nrf2-Dependent Mechanism
ACTH-like Peptides Compensate Rat Brain Gene Expression Profile Disrupted by Ischemia a Day After Experimental Stroke
The Association Between Serum MOTS-c Levels and Myocardial Ischemia–Reperfusion Injury in Patients with Acute Myocardial Infarction: A Cross-Sectional Study
Protective Effects of PGC-1α Activators on Ischemic Stroke in a Rat Model of Photochemically Induced Thrombosis
Insight into Glyproline Peptides’ Activity through the Modulation of the Inflammatory and Neurosignaling Genetic Response Following Cerebral Ischemia–Reperfusion
Synthetic Adrenocorticotropic Peptides Modulate the Expression Pattern of Immune Genes in Rat Brain following the Early Post-Stroke Period
Brain Protein Expression Profile Confirms the Protective Effect of the ACTH(4–7)PGP Peptide (Semax) in a Rat Model of Cerebral Ischemia–Reperfusion
Antistress Action of Melanocortin Derivatives Associated with Correction of Gene Expression Patterns in the Hippocampus of Male Rats Following Acute Stress
Genes That Associated with Action of ACTH-like Peptides with Neuroprotective Potential in Rat Brain Regions with Different Degrees of Ischemic Damage
Digitally Guided Hybrid Maxillary Expansion with Supragingival Mandibular Miniplates for Class III Correction in Late Adolescents: A Pilot Clinical Study
MOTS-c Levels and Sarcopenia Risk in Chronic Peritoneal Dialysis Patients: A Pilot Study
Whey Protein Supplementation Compared to Collagen Increases Blood Nesfatin Concentrations and Decreases Android Fat in Overweight Women: A Randomized Double-Blind Study
A Collagen Supplement Improves Skin Hydration, Elasticity, Roughness, and Density: Results of a Randomized, Placebo-Controlled, Blind Study
Effects of a Combination of Water-Soluble Coenzyme Q10 and Collagen on Skin Parameters and Condition: Results of a Randomised, Placebo-Controlled, Double-Blind Study
Evaluation of Coronary Flow Level with Mots-C in Patients with STEMI Undergoing Primary PCI
Strategy to discover full-length amyloid-beta peptide ligands using high-efficiency microarray technology
Tesamorelin: A hope for ART- induced lipodystrophy
Late-life restoration of mitochondrial function reverses cardiac dysfunction in old mice
Online-Sourced Retatrutide Complicating Impending Diabetic Ketoacidosis in a Patient With Type 1 Diabetes and Concurrent Shigella Gastroenteritis
Comparison of Serum Mitochondrial Open Reading Frame of the 12S rRNA-c (MOTS-c) Levels in Patients With Multiple Sclerosis and Healthy Controls
Carpal Tunnel Syndrome Attributed to Medication Use: A Pharmacovigilance Study
1499. Tesamorelin Reduces Visceral Adipose Tissue and Liver Fat in INSTI-Treated Persons with HIV
P-433. Impact of Tesamorelin on Cardiovascular Disease Risk Prediction Scores in Phase 3 Studies Treatment Arms: Subanalysis
P-1230. Tesamorelin (EGRIFTA WR and EGRIFTA®) Formulations: Bioequivalence in Healthy Participants
Safety and Tolerability of Concomitant Administration of Multiple-Dose AM833 With Semaglutide 2.4 MG for Weight Management
Preclinical Weight Loss Efficacy of AM833 in Combination With Semaglutide in Rodent Models of Obesity
Growth Hormone Releasing Hormone Reduces Plasma Markers of Immune Activation and Hepatic Immune Pathways in Nonalcoholic Fatty Liver Disease
Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder Two Randomized Phase 3 Trials
Bremelanotide for female sexual dysfunctions in premenopausal women: a randomized, placebo-controlled dose-finding trial
Usefulness of ambulatory blood pressure monitoring to assess the melanocortin receptor agonist bremelanotide
Effect of bremelanotide on body weight of obese women: Data from two phase 1 randomized controlled trials
Long-Term Safety and Efficacy of Bremelanotide for Hypoactive Sexual Desire Disorder
Critical Role of PepT1 in Promoting Colitis-Associated Cancer and Therapeutic Benefits of the Anti-inflammatory PepT1-Mediated Tripeptide KPV in a Murine Model
Structural modification of the tripeptide KPV by reductive “glycoalkylation” of the lysine residue
AEDG Peptide (Epitalon) Stimulates Gene Expression and Protein Synthesis during Neurogenesis: Possible Epigenetic Mechanism
Epitalon protects against post-ovulatory aging-related damage of mouse oocytes in vitro
Epitalon increases telomere length in human cell lines through telomerase upregulation or ALT activity
The Antioxidant Tetrapeptide Epitalon Enhances Delayed Wound Healing in an in Vitro Model of Diabetic Retinopathy
The efficacy of thymosin alpha 1 for severe sepsis (ETASS): a multicenter, single-blind, randomized and controlled trial
Thymosin alpha 1 in the prevention of infected pancreatic necrosis following acute necrotising pancreatitis (TRACE trial): protocol of a multicentre, randomised, double-blind, placebocontrolled, parallel-group trial
A pilot trial of Thymalfasin (Ta1) to prevent covid-19 infection and morbidities in renal dialysis patients: Preliminary report
Neoadjuvant immunochemotherapy plus thymalfasin in locally advanced gastric cancer: a prospective clinical trial
A Case Report of a Multisystemic Immune-Related Adverse Event Caused by Sintilimab in Combination With Thymosin Alpha-1
Thymosin α1 therapy in critically ill patients with COVID-19: A multicenter retrospective cohort study
Thymosin Alpha 1 Mitigates Cytokine Storm in Blood Cells From Coronavirus Disease 2019 Patients
The effect of thymosin α1 on mortality of critical COVID-19 patients: A multicenter retrospective study
Impact of thymosin α1 as an immunomodulatory therapy on long-term survival of non-small cell lung cancer patients after R0 resection: a propensity score-matched analysis
Efficacy Evaluation of Thymosin Alpha 1 in Non-severe Patients With COVID-19: A Retrospective Cohort Study Based on Propensity Score Matching
A Double-blind Multicenter Two-arm Randomized Placebo-controlled Phase-III Clinical Study to Evaluate the Effectiveness and Safety of Thymosin α1 as an Addon Treatment to Existing Standard of Care Treatment in Moderate-to-severe COVID-19 Patients
Efficacy of Thymosin Alpha 1 in the Treatment of COVID-19: A Multicenter Cohort Study
Thymosin Alpha-1 Has no Beneficial Effect on Restoring CD4+ and CD8+ T Lymphocyte Counts in COVID-19 Patients
A Pilot Trial of Thymalfasin (Tα1) to Treat Hospitalized Patients with Hypoxemia and Lymphocytopenia due to COVID-19 Infection
Clinical efficacy of thymosin alpha 1 combined with multi-modality chemotherapy and its effects on immune function of patients with pulmonary tuberculosis complicated with diabetes
Evaluation of the efficacy and safety of a precise thymalfasin-regulated PRaG regimen for advanced refractory solid tumours: protocol for the open-label, prospective, multicentre study (PRaG5.0 study
Indications for an antidepressive effect of thymosin alpha-1 in a small open-label proof of concept study in common variable immune deficiency patients with depression
Thymosin α1 Elevates Lymphocyte Counts and Improves Immunoradiotherapy Outcomes in Patients with Advanced Cancer
Thymosin α1 combined with XELOX improves immune function and reduces serum tumor markers in colorectal cancer patients after radical surgery
Exploiting the potential of in situ forming liquid crystals: development and in vitro performance of long-acting depots for peptide drug thymosin alpha 1 subcutaneous administration
Changes in Oral Mucosa Associated with Melanotan II Injections: A Case Report
Melanotan-II reverses autistic features in a maternal immune activation mouse model of autism
Topical MTII Therapy Suppresses Melanoma Through PTEN Upregulation and Cyclooxygenase II Inhibition
Inhibitory Effect of the Melanocortin Receptor Agonist Melanotan-II (MTII) on Feeding Depends on Dietary Fat Content and not Obesity in Rats on Free-Choice Diets
The first preparative solution phase synthesis of melanotan II
DSIP-Like KND Peptide Reduces Brain Infarction in C57Bl/6 and Reduces Myocardial Infarction in SD Rats When Administered during Reperfusion
Delta Sleep-Inducing Peptide Recovers Motor Function in SD Rats after Focal Stroke
Pichia pastoris secreted peptides crossing the blood-brain barrier and DSIP fusion peptide efficacy in PCPA-induced insomnia mouse models
Effects of GHRP-2 and Cysteamine Administration on Growth Performance, Somatotropic Axis Hormone and Muscle Protein Deposition in Yaks (Bos grunniens) with Growth Retardation
Clinical Usefulness of the Growth Hormone–Releasing Peptide-2 Test for Hypothalamic-Pituitary Disorder
LBODP006 Clinical Usefulness Of The Growth Hormonereleasing Peptide-2 Test For Hypothalamic-pituitary Disorder
One-year intranasal application of growth hormone releasing peptide-2 improves body weight and hypoglycemia in a severely emaciated anorexia nervosa patient
Evaluation of Hypothalamic–Pituitary– Adrenal Axis by the GHRP2 Test: Comparison With the Insulin Tolerance Test
Growth hormone response to growth hormonereleasing peptide-2 in growth hormone-deficient Little mice
Growth Hormone Releasing Peptide-2 Attenuation of Protein Kinase C-Induced Inflammation in Human Ovarian Granulosa Cells
The Ghrelin Analog GHRP-6, Delivered Through Aquafeeds, Modulates the Endocrine and Immune Responses of Sparus aurata Following IFA Treatment
Growth hormone releasing peptide-6 (GHRP-6) prevents doxorubicin-induced myocardial and extra-myocardial damages by activating prosurvival mechanisms
Growth Hormone-Releasing Peptide 6 Enhances the Healing Process and Improves the Esthetic Outcome of the Wounds
Growth hormone-releasing peptide 6 (GHRP- 6) hydrogel for acute kidney injury therapy via metabolic regulation
Potassium Current Is Not Affected by Long-Term Exposure to Ghrelin or GHRP-6 in Somatotropes GC Cells
Growth Hormone-Releasing Peptide-6 (GHRP-6) Ameliorates Post-Infarct Ventricular Remodeling and Systolic Dysfunction in a Model of Permanent Coronary Ligation
Changes in Locomotor Activity Observed During Acute Nicotine Withdrawal Can Be Attenuated by Ghrelin and GHRP-6 in Rats
Efficacy of LL‑37 cream in enhancing healing of diabetic foot ulcer: a randomized double‑blind controlled trial
Discovery of novel antibacterial agent for the infected wound treatment: all-hydrocarbon stapling optimization of LL-37
Role of LL‑37 in thrombotic complications in patients with COVID‑19
Influence of Lipidation Pattern of the KR12 Fragment of Peptide LL-37 on Its Antibacterial and Hemolytic Activities
Self-assembly of PEG–PPS polymers and LL-37 peptide nanomicelles improves the oxidative microenvironment and promotes angiogenesis to facilitate chronic wound healing
LL-37-Coupled Porous Composite Scaffold for the Treatment of Infected Segmental Bone Defect
LL‑37 regulates odontogenic differentiation of dental pulp stem cells in an inflammatory microenvironment
Interactions of Laurylated and Myristoylated KR12 Fragment of the LL37 Peptide with Polyoxidovanadates
Glioblastoma Multiforme: Sensitivity to Antimicrobial Peptides LL-37 and PG-1, and Their Combination with Chemotherapy for Predicting the Overall Survival of Patients
Anticandidal Activity of Lipopeptides Containing an LL-37-Derived Peptide Fragment KR12
Assessment of Antimicrobial Activity of LL‑37 Peptide Against Periapical Pathogens: A Cross‑Sectional Study
Genetically Modified Mesenchymal Stromal/Stem Cells as a Delivery Platform for SE-33, a Cathelicidin LL-37 Analogue: Preclinical Pharmacokinetics and Tissue Distribution in C57BL/6 Mice
Synthesis and evaluation of KR-12, an LL-37 fragment, and its shortchain fatty acid derivatives: selective cytotoxicity in colorectal cancer cells and anti-tumor efficacy in an azoxymethane/DSS-induced colitisassociated cancer mouse model
Development and Characterization of LL37 Antimicrobial-Peptide-Loaded Chitosan Nanoparticles: An Antimicrobial Sustained Release System
Suramin blocked hCAP18/LL-37-induced macrophage recruitment and M2 polarization to enhance the therapeutic efficacy of 1,25(OH)2D3 against hepatocellular carcinoma in vitro and in vivo mouse model
Plasma levels of antimicrobial peptide LL-37 as a biomarker of sleep quality in patients with obstructive sleep apnea: A clinical observational study
LL-37 IgG levels are associated with clinical characteristics and T follicular cell response in acute coronary syndrome in adults
Comparing the genetic and serum expression of LL-37 Antimicrobial Peptide in pemphigus vulgaris and pemphigus foliaceus patients
Interaction between vitamin D insufficiency and periodontitis, GCF vitamin D and LL-37 levels in well-controlled diabetes patients with periodontitis
Hexarelin treatment preserves myocardial function and reduces cardiac fibrosis in a mouse model of acute myocardial infarction
Improvement of cardiomyocyte function by in vivo hexarelin treatment in streptozotocin-induced diabetic rats
Enhanced Pulsatile Growth Hormone Secretion and Altered Metabolic Hormones by in Vivo Hexarelin Treatment in Streptozotocin-Induced Diabetic Rats
Growth hormone secretagogues hexarelin and JMV2894 protect skeletal muscle from mitochondrial damages in a rat model of cisplatin-induced cachexia
Effect of paracellular permeation enhancers on intestinal permeability of two peptide drugs, enalaprilat and hexarelin, in rats
The In Vivo Effect of Transcellular Permeation Enhancers on the Intestinal Permeability of Two Peptide Drugs Enalaprilat and Hexarelin
Hexarelin alleviates apoptosis on ischemic acute kidney injury via MDM2/p53 pathway
Hexarelin Protects Rodent Pancreatic Β-Cells Function from Cytotoxic Effects of Streptozotocin Involving Mitochondrial Signalling Pathways In Vivo and In Vitro
Hexarelin Modulation of MAPK and PI3K/Akt Pathways in Neuro-2A Cells Inhibits Hydrogen Peroxide—Induced Apoptotic Toxicity
Modulation of PTEN by hexarelin attenuates coronary artery ligation-induced heart failure in rats
Hexarelin modulates lung mechanics, inflammation, and fibrosis in acute lung injury
Protective Effects of Hexarelin and JMV2894 in a Human Neuroblastoma Cell Line Expressing the SOD1-G93A Mutated Protein
Using Synchrotron Radiation Imaging Techniques to Elucidate the Actions of Hexarelin in the Heart of Small Animal Models
Hexarelin promotes the survival of retinal ganglion cells after optic nerve transection
Rising Use of Unapproved BPC-157 (“Wolverine Peptide”) and Associated Patient-Reported Outcomes Curated from Clinical Notes
- Population
- Human
- Finding and limits
- This unreviewed preprint identified 1,039 documented users, with response direction missing for 685. Missing outcomes, co-treatments and an absent control group prevent a treatment-effect estimate.
Relevant PDF pages: 9, 11.
Stable Gastric Pentadecapeptide BPC 157 as Therapy After Surgical Detachment of the Quadriceps Muscle from Its Attachments for Muscle-to-Bone Reattachment in Rats
- Population
- Male albino Wistar rats
- Finding and limits
- The investigators reported improved quadriceps reattachment and walking after experimentally detaching muscle from bone. The oral rat regimen does not establish human oral absorption or recovery.
Relevant PDF pages: 8.
Modulatory effect of gastric pentadecapeptide BPC 157 on angiogenesis in muscle and tendon healing
- Population
- Male Wistar albino rats and endothelial-cell culture
- Finding and limits
- Animal tissues showed changes in angiogenic-marker timing, while the cell-culture tube-branching assay found no significant difference. These are assay-specific findings, with inconsistent concentration units reported in the paper.
Relevant PDF pages: 2, 3.
BPC157 drives angiogenesis through FBXO22-dependent stabilization of BACH1
- Population
- Human endothelial-cell cultures and rodent tissue-injury models
- Finding and limits
- The paper reports endothelial-cell tube formation and an FBXO22/BACH1 mechanism. Conflicting animal routes, doses and sample descriptions prevent a reliable animal dose–response interpretation here.
Animal dose and sample-size claims are withheld pending clarification of reporting discrepancies.
Relevant PDF pages: 3, 4.
Quality measurements
Product and manufacturing measurements from the packet, filed as quality records.
Endotoxin measurements
The study records below provide the methods, measured outcomes, and reported observations needed to interpret the research linked to this page. Open a record to inspect its population or experimental model, formulation, route, and limitations alongside the original source details. Numerical excerpts retain their source filename and PDF page so that they can be checked in context. A study’s presence in this list does not by itself establish clinical benefit, combination effectiveness, or a recommended treatment schedule.
| Source | DOI | Record |
|---|---|---|
| 10.3390/pharmaceutics18091110 | ||
| 10.1371/journal.pone.0286752 |
Questions worth exploring
What people are asking about peptides, and what to look for in the research.
BPC-157Does BPC-157 help tendon or ligament injuries in humans?
Research focusHuman tendon healing, pain relief, and the limits of animal studies.
BPC-157Is oral BPC-157 as effective as injected BPC-157?
Research focusHuman studies of absorption and outcomes with oral and injected BPC-157.
BPC-157What human evidence exists for BPC-157?
Research focusHuman trial design, study size, comparisons, and how side effects were tracked.
BPC-157Does BPC-157 need to be injected near an injury to work?
Research focusWhether human studies have compared outcomes at different injection sites.
BPC-157Does BPC-157 increase cancer risk?
Research focusTheories about cancer risk, observed outcomes, and gaps in long-term safety data.
BPC-157Does BPC-157 help peripheral nerve pain or nerve injury?
Research focusHuman nerve pain and injury outcomes, considered separately from tendon and animal research.
TB-500 / thymosin beta-4Are TB-500 and thymosin beta-4 the same molecule?
Research focusMolecule identity, peptide fragments, and the products used in each study.
TB-500 / thymosin beta-4Does TB-500 improve recovery or scarring after surgery?
Research focusWhich molecules and routes were studied in wound healing and eye trials.
BPC-157 / TB-500Is a BPC-157 and TB-500 combination better than either peptide alone?
Research focusDirect comparisons of the combination and each peptide used alone.
GHK-CuDoes topical GHK-Cu improve skin appearance?
Research focusControlled human studies of skin products, measured changes, and treatment length.
GHK-CuAre GHK-Cu injections better than topical products for skin?
Research focusSkin outcomes and safety in human comparisons of topical and injected products.
GHK-CuCan topical GHK-Cu reach and repair deeper muscles or ligaments?
Research focusSkin absorption and whether deeper tissue delivery has been studied.
CJC-1295 / ipamorelinDo CJC-1295 and ipamorelin improve sleep?
Research focusThe molecules, combinations, study groups, and sleep measures used in trials.
CJC-1295 / ipamorelinDo CJC-1295 and ipamorelin build muscle in healthy adults?
Research focusMeasured muscle and performance outcomes, alongside GH and IGF-1 findings.
CJC-1295 / ipamorelinHow do CJC-1295 and ipamorelin affect blood glucose or insulin sensitivity?
Research focusMeasured blood sugar effects and risks for each compound.
Semaglutide / tirzepatideDoes tirzepatide produce more weight loss than semaglutide?
Research focusDirect trial comparisons, study groups, doses, follow-up, and side effects.
SemaglutideWhat happens to weight after semaglutide is stopped?
Research focusWeight changes during treatment and follow-up after treatment ends.
SemaglutideDoes semaglutide-associated weight loss include lean mass loss?
Research focusLean mass, muscle, and strength measures, including amounts and proportions lost.
Collagen peptidesDo oral collagen peptides improve skin hydration or wrinkles?
Research focusRandomized trials, the products tested, study size, and funding.
Collagen peptidesDo oral collagen peptides improve hair, nails or joint symptoms?
Research focusSeparate evidence for hair, nail, and joint outcomes.
Quality and safetyDoes a high purity result prove a peptide is sterile or safe?
Research focusWhat tests measure about purity, identity, content, sterility, and endotoxins.
Quality and safetyWhat does a research-use-only label establish about safety?
Research focusThe meaning of the label, approval status, and safety evidence in each jurisdiction.
Quality and safetyCan general online storage advice establish a peptide product's shelf life?
Research focusStability and shelf-life data for the specific product and formulation.
Selected public discussions help us choose questions. They are not clinical evidence.